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1	
INTRODUCTION	
Part	of	this	literature	was	integrally	published	in	Cell	Calcium	(volume	66:	48-61,	2017)	of	which	
Lucía	Alonso-Carbajo	is	first	author.	
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Fine-tuned	 regulation	 of	 the	 arterial	 pressure	 is	 an	 essential	 physiological	 process	
determined	 by	 two	 important	 parameters,	 cardiac	 output	 (CO)	 and	 total	 peripheral	
resistance	 (TPR).	 The	 deregulation	 of	 the	 blood	 pressure	 can	 lead	 to	 cause	 severe	
vascular	disorders	over	time	and	even	sudden	death.	Multiple	pathways	including	the	
autonomic	 nervous	 system,	 renin–angiotensin	 system,	 aldosterone,	 vasoactive	
substances	 and	 vascular	 responses	 to	 external	 changes	 affect	 CO	 and	 TPR	 to	 tightly	
regulate	 vascular	 functions	 and	 thus	 ensure	 appropriate	 blood	 flow	 along	 the	 body.	
Arteries	with	small	diameters,	also	called	resistance	arteries,	contribute	significantly	to	
the	regulation	and	creation	of	resistance	to	blood	flow	in	order	to	maintain	a	normal	
arterial	pressure	[1].	
1.1	The	resistance	arteries	
1.1.1	The	vascular	wall	
Resistant	arteries	are	normally	 in	a	partial	 contraction	state	which	 is	known	as	basal	
tone,	from	which	they	can	constrict	further	or	dilate	depending	on	the	tissue	demand	
for	 blood [2],	 allowing	 blood	 flow	 changes	 in	 response	 to	 local	 stimuli.	 When	 the	
resistance	 artery	 is	 dilated,	 the	 resistance	 is	 decreased	 and	 the	 local	 blood	 flow	
increases.	On	 the	contrary,	 the	vasoconstriction	of	 these	small	arteries	 increases	 the	
local	resistance	and	decreases	the	blood	flow	to	the	tissues	[1].	The	wall	of	these	arteries	
is	formed	by	three	layers:	tunica	intima,	tunica	media	and	tunica	adventitia	(Figure	1.1).	
1.1.1.1	Tunica	intima	
The	 tunica	 intima	 is	 the	 innermost	 layer	and	 it	 is	 composed	of	endothelial	 cells	 (EC)	
surrounded	by	a	fine	network	of	connective	tissue.	EC	lining	the	vascular	lumen	of	the	
vessel	are	 sealed	 to	each	other	by	“tight	 junctions”,	 restricting	 the	diffusion	of	 large	
molecules	across	the	endothelium.	The	EC	constitute	a	semipermeable	layer	that	retains	
the	escape	of	plasma	and	the	blood	cellular	components	in	the	circulation,	and	allow	
the	circulation	of	nutrients	between	the	blood	and	the	tissues.	The	glycocalyx	and	the	
intercellular	 junctions	play	a	 crucial	 role	 in	 controlling	 the	permeability	of	 this	 layer.	
These	structures	are	very	permeable	to	gases	and	ions	and	also	to	other	small	molecules	
such	as	hormones	and	metabolites	(glucose,	amino	acids,	etc.),	but	prevent	the	diffusion	
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of	 large	 molecules	 such	 as	 the	 plasma	 proteins.	 The	 endothelium	 also	 secretes	
vasoactive	agents	such	as	nitric	oxide	(NO)	that	can	act	on	the	adjacent	vascular	smooth	
muscle	cells	(VSMC)	resulting	in	vasodilation	[1,	3].	
1.1.1.2	Tunica	media	
The	 tunica	 media	 is	 the	 middle	 layer	 of	 the	 vessel	 wall	 and	 is	 responsible	 for	 the	
mechanical	activity	of	the	artery.	This	layer	contains	VSMC	that	are	helically	embedded	
in	 an	 extracellular	matrix	mainly	 formed	by	 elastin	 and	 collagen	 fibres;	 their	 activity	
contracts	or	dilates	the	artery.	The	tunica	media	is	limited	by	the	internal	and	external	
elastic	 laminas,	 composed	 of	 elastin,	 which	
allows	 the	 resistance	 arteries	 to	 dilate	 or	
contract,	 preventing	 large	 changes	 in	 the	
blood	 flow.	 Gap	 junctions	 are	 formed	
between	VSMC	allowing	ions	to	flow	from	one	
cell	 to	 another	 and	 spreading	 the	
depolarization	across	adjacent	cells	[4].	VSMC	
contraction	 depends	 on	 cross-bridge	
formation	 between	 myosin	 and	 actin	
filaments,	which	promotes	sliding	of	the	actin	
filaments	 along	 the	 myosin,	 shortening	 the	
cell	and	causing	muscle	contraction.	
1.1.1.3	Tunica	adventitia	
The	tunica	adventitia	is	the	outer	layer	and	is	
mainly	composed	of	connective	tissue	sheath	with	no	distinct	outer	border.	An	external	
elastic	lamina	separates	the	tunica	media	from	the	adventitia.	The	principal	function	of	
the	adventitia	is	to	keep	the	vessel	attached	to	the	surrounding	tissue.	It	also	contains	
collagen	 fibres	 that	 serve	 as	 support	 for	 fibroblasts	 and	 small	 vessels	 to	 provide	
nutrients	to	the	wall	of	large	vessels	(the	“vasa	vasorum”,	literally	“vessels	of	vessels”)	
and	 very	 importantly,	 sympathetic	 and	 sensory	 fibre	 terminals.	 Release	 of	
neurotransmitters	(NTs)	by	activation	of	these	fibres	contributes	to	the	regulation	of	the	
local	vessel	resistance	and	the	blood	flow	[1,	5].	
Figure	 1.1.	 Schematic	 description	 of	 the	
structure	of	a	resistance	artery	wall	formed	
by	three	layers:	tunica	intima,	tunica	media	
and	 tunica	 adventitia	 (Wagenseil	 et	 al.,	
2009).	
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1.2	Perivascular	nerves	
Resistance	arteries	are	primarily	 innervated	by	the	sympathetic	and	sensory	neurons	
which	can	release	different	NTs	 (Figure	1.2).	These	NTs	bind	 to	specialized	receptors	
such	 as	 α-adrenergic	 receptors	 and	 G	 protein-coupled	 receptors	 (GPCR)	 present	 in	
VSMC	and	EC.	The	fine	balance	between	the	influence	of	the	sympathetic	and	sensory	
nervous	systems	tightly	regulates	the	vascular	tone	[6].		
	
Figure	1.2.	Anatomical	 location	of	perivascular	 sympathetic	and	sensory	nerves.	Perivascular	
nerves	are	located	in	the	adventitia	and	can	make	direct	contact	with	VSMC	or	EC.	Purinergic	
and	transient	receptor	potential	(TRP)	channels	expressed	in	both	types	of	nerves	are	involved	
in	 the	 release	 of	multiple	NTs.	While	 efferent	 sympathetic	 fibres	 can	 release	 noradrenaline,	
sensory	nerve	axons	are	able	to	release	calcitonin	gen-related	peptide	(Adapted	from	Westcott,	
E.B.	et	al.,	2013).	
1.2.1	The	sympathetic	nervous	system		
The	 presence	 and	 functional	 role	 of	 parasympathetic	 perivascular	 nerves	 is	 poorly	
defined	relative	to	those	of	sympathetic	or	sensory	perivascular	nerves.	While	in	some	
vascular	beds,	parasympathetic	nerves	may	play	a	minor	role	in	vasomotor	function,	in	
most	 vessels	 there	 is	 no	 presence	 of	 these	 innervation	 [7].	 Blood	 vessels	 are	 richly	
innervated	by	sympathetic	vasoconstrictor	nerves,	constituting	a	key	system	to	control	
the	total	peripheral	resistance.	The	sympathetic	nerves	arise	from	little	collections	of	
small	neuronal	clusters	located	ventral	and	lateral	to	the	spinal	cord [8].		
1.2.1.1	Structure	and	action	mechanism	of	sympathetic	nervous	system	
The	sympathetic	nervous	system	(SNS)	is	formed	by	clusters	of	neuron	cell	bodies	called	
ganglia.	 Sympathetic	 ganglia	 are	 divided	 into	 two	 main	 groups,	 prevertebral	 and	
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paravertebral,	 depending	 on	 their	 localization	 in	 the	 body.	 Prevertebral	 ganglia	 also	
called	collateral	ganglia	innervate	organs	of	the	abdominal	region	and	are	lying	between	
the	 paravertebral	 ganglia	 and	 the	 target	 organ,	 whereas	 paravertebral	 ganglia	 are	
located	ventral	and	lateral	to	the	spinal	cord	forming	the	sympathetic	chain	ganglia.	The	
chain	extends	from	the	upper	neck	down	to	the	coccyx.		
In	mammals,	 there	 are	 22	 pairs	 of	 these	 ganglia:	 3	 in	 the	 cervical	 region,	 11	 in	 the	
thoracic	 region,	4	 in	 the	 lumbar	 region,	and	4	or	5	 in	 the	sacral	 region.	The	superior	
ganglia	innervate	the	head,	and	the	middle	innervate	the	neck,	heart	and	upper	limbs.	
The	 thoracic	 sympathetic	 ganglia	 are	 connected	 to	 the	 prevertebral	 ganglia	 that	
innervate	 the	 trunk	 region,	 and	 finally	 the	 lumbar	 and	 sacral	 sympathetic	 ganglia	
innervate	the	pelvic	floor	and	lower	limbs.		
There	are	two	types	of	neurons	involved	in	the	transmission	of	any	signal	through	the	
sympathetic	system:	pre-ganglionic	and	post-ganglionic.	The	chemical	transmission	in	
the	sympathetic	system	appears	simple:		preganglionic	nerves	originate	from	the	spinal	
cord	travel	to	a	paravertebral	ganglion	or	to	a	prevertebral	ganglion	in	the	case	of	the	
thoracic	preganglionic	neurons,	where	they	synapse	with	a	postganglionic	fibre,	which	
extends	to	an	effector	tissue.	The	distance	between	pre-	and	postsynaptic	membranes	
can	be	quite	large	compared	with	typical	synapses.	For	instance,	the	gap	between	cell	
membranes	 of	 a	 typical	 chemical	 synapse	 is	 30	 –	 50	 nanometres,	whereas	 in	 blood	
vessels	 the	 distance	 between	 the	 synaptic	 end	of	 the	 post-ganglionic	 axons	 and	 the	
vascular	tissue	is	often	greater	than	100	nanometres	or,	in	some	cases,	1–2	µm.	Also,	
unlike	 classical	 synapses,	 there	 is	 not	 a	 single	 site	 of	 neurotransmitter	 release	 from	
sympathetic	nerves.	Instead,	neurotransmitter	is	released	“en	passant”	from	varicosities	
along	the	efferent	axons	and	over	a	widespread	area	of	the	target	tissue.	In	this	way,	a	
relatively	 small	 number	 of	 neurons	 can	 exert	 control	 of	 large	 tissue	 areas.	 The	
neurotransmitter	released	at	the	synapsis	between	pre-	and	post-	ganglionic	fibres	 is	
acetylcholine	(ACh),	alone	or	in	combination	with	other	peptide	co-transmitters.	These	
NTs	 activate	 nicotinic	 and	 peptidergic	 receptors	 on	 postganglionic	 neurons.	 The	
activation	of	 these	postganglionic	neurons	 lead	to	the	release	of	noradrenaline	(NA),	
again	alone	or	in	combination	with	other	NTs	on	the	target	organs	(Figure	1.3).		
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NA	 is	 formed	 by	 a	 complex	 process	 whereby	 tyrosine	 is	 catalyzed	 by	 the	 enzyme	
tyrosine-hydroxylase	 (TH)	 resulting	 in	 levodopa	 (L-DOPA).	 L-DOPA	 is	 transformed	 to	
dopamine	due	to	 the	activity	of	DOPA	decarboxylase	and	stored	 in	synaptic	vesicles.	
Within	 these	 vesicles,	 dopamine-α-hydroxylase	 is	 the	 responsible	 for	 transforming	
dopamine	into	the	final	NA,	which	triggers	contraction	of	the	VSMC.		
	
	
Figure	1.3.	Sympathetic	neuromuscular	transmission.	Noradrenaline	secreted	by	postganglionic	
neurons	binds	to	α1-receptors	located	in	VSMC	leading	to	vasoconstriction	via	phospholipase	C	
pathway	(Levick	J.R.,	2003).	
However,	neurotransmission	is	more	complex,	because	multiple	peptides	are	released,	
affecting	 different	 receptors	 on	 the	 target	 cell.	 In	 addition,	 all	 these	 NTs	 are	 self-
regulatory,	 in	 the	sense	 that	 they	act	on	presynaptic	 receptors	 located	on	 their	own	
axon	terminals	[9].		
Owing	 to	 the	 large	 gaps	 between	 autonomic	 nerve	 terminals	 and	 their	 effector	
cells,	 NTs	 tend	 also	 to	 act	 slowly	 or	 become	 inactivated.	 However,	 the	 widespread	
nature	of	these	connections,	together	with	the	existence	of	low-resistance	connections	
among	VSMC,	allow	many	cells	responding	as	a	group	upon	activation	of	only	one	cell.	
1.2.1.2	Role	of	sympathetic	nervous	system	in	vascular	function	
The	SNS	is	responsible	for	regulating	many	homeostatic	mechanisms	in	the	organisms.	
In	resistance	arteries,	sympathetic	vasoconstrictor	fibres	are	tonically	active	releasing	
NA	 that	 binds	mainly	 to	a1-adrenergic	 receptors	 located	 in	 the	VSMC,	 resulting	 in	 a	
constriction	of	the	blood	vessels	[10].	This	means	that	a	reduced	sympathetic	vasomotor	
activity	causes	vasodilatation [7].	 In	addition,	VSMC	also	express	β2-adrenoreceptors,	
whose	activation	by	NA	may	 induce	arterial	dilation	 [11].	However,	 the	predominant	
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action	of	NA	released	from	sympathetic	nerves	of	resistance	vessels	is	consistently	with	
a	vasoconstriction,	so	that	the	physiological	role	of	β2-adrenoreceptors	in	the	control	of		
vascular	tone	remains	to	be	established	[6].	
Alterations	of	the	sympathetic	regulation	of	vessels	are	involved	in	some	diseases,	such	
as	Raynaud's	syndrome.	This	phenomenon	is	associated	with	a	hyperactivation	of	the	
SNS	causing	peripheral	vasoconstriction,	leading	to	tissue	hypoxia.	This	hyperactivation,	
that	normally	occurs	in	response	to	low	ambient	temperature	and	is	directed	to	avoid	
heat	 loss	through	the	skin,	 is	usually	followed	after	a	few	minutes	by	a	“paradoxical”	
vasodilation	 in	 healthy	 patients.	 Both	 the	 activation	 of	 the	 sympathetic	
neurotransmission	together	with	the	local	release	of	vasodilator	substances	activated	
by	tissue	hypoxia	are	responsible	for	the	read	noses	and	ears	when	patients	are	exposed	
to	 very	 low	 temperatures	 for	prolonged	 times.	 This	 vasodilation	does	not	happen	 in	
Raynaud's	patients.	Possible	alterations	may	include	the	increased	sensitivity	to	cold	of	
the	adrenergic	 receptors,	 increased	 levels	of	 locally	 released,	 systemically	 circulating	
vasoconstrictors	 or	 a	 deficiency	 or	 increased	 degradation	 of	 NO	 due	 to	 augmented	
oxidative	stress.	 In	any	case,	 the	only	available	 treatment	 to	date	 is	 the	sympathetic	
denervation	of	cutaneous	vessels	[12].	
A	role	of	the	SNS	in	the	treatment	of	essential	hypertension	has	also	been	proposed.	
Several	studies	have	found	significantly	higher	plasma	NA	levels	in	hypertensive	subjects	
compared	 to	 healthy	 patients	 [13].	 Furthermore,	 the	 association	 of	 obesity,	
hypertension,	 insulin	 resistance,	 and	 type-2	 diabetes	 can	 be	 partially	 explained	 by	
interactions	between	insulin	and	the	SNS	[14].	This	has	led	to	a	renewed	interest	in	α-
adrenergic	 inhibitory	 approaches	 for	 the	 treatment	 of	 hypertension	 and	 other	
cardiovascular	and	metabolic	diseases	[15,	16].	
1.2.2	The	sensory	nervous	system	
Sensory	peripheral	nerves	are	associated	with	VSMC.	The	expression	of	neurotrophic	
factors	such	as	nerve	growth	factor	(NGF)	and	neurotrophin-3	(NT3)	in	blood	vessels	is	
thought	to	be	important	to	maintain	the	survival	of	growing	axons	before	they	arrive	at	
their	peripheral	targets,	which	provide	an	independent	source	of	neurotrophins	[17].	In	
mutant	embryos	lacking	sensory	nerves,	arteries	fail	to	properly	differentiate,	while	in	
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those	containing	disorganized	nerves	the	trajectory	of	blood	vessel	branching	is	altered	
to	follow	the	nerves	[18]. 	
1.2.2.1	Structure	and	action	mechanism	of	sensory	nervous	system	
The	sensory	peripheral	nervous	system	(SPNS)	is	formed	mainly	by	nerves	that	collect	
information	 from	 receptors	 present	 in	 their	 terminals.	 Unlike	 sympathetic	 nerves,	
sensory	nerves	are	capable	of	both	antidromic	conduction	in	response	to	a	short	reflex	
and	orthodromic	conduction	that	is	caused	by	a	long-term	reflex,	thereby	enabling	their	
participation	in	local	axon	reflexes	independent	of	efferent	signalling	from	the	cell	body.		
In	 a	 short	 reflex,	 these	 sensory	 neurons	 are	 able	 to	 monitor	 conditions	 inside	 and	
outside	of	the	body	and	synapse	directly	in	a	peripheral	ganglion	with	other	nerve	fibre.	
On	the	contrary,	in	long-term	reflexes	the	sensory	neurons	send	this	information	to	the	
central	nervous	system	(CNS)	that	would	be	further	processed	in	the	peripheral	ganglion	
(Figure	1.4).	Thus,	noxious	stimuli	can	cause	antidromic	stimulation	of	sensory	nerves,	
leading	to	neurotransmitter	release	and	vasodilation,	in	addition	to	the	sensation	of	pain	
(the	long-term	reflex,	orthodromic).		
Sensory	nerves	endings	are	free	dendrites	that	extend	into	the	target	tissue.	These	free	
nerves	endings	are	able	to	sense	stimuli	including	pain,	heat	and	cold.	After	the	blockade	
of	cholinergic	and	noradrenergic	transmissions,	blood	vessels	can	still	actively	be	dilated	
in	response	to	nerve	stimulation.	There	 is	strong	evidence	that	these	non-adrenergic	
and	non-cholinergic	vasodilator	neurons	are	sensory	fibres	that	secrete	peptides	such	
as	 the	 calcitonin	 gene-related	 peptide	 (CGRP)	 and	 substance	 P	 (SP).	 In	 the	 vascular	
system,	CGRP	has	been	identified	as	the	main	neurotransmitter	released	from	sensory	
neurons	[19].	These	NTs	bind	to	their	specific	receptors	present	in	the	media	and	intima	
layers	of	the	blood	vessels	modulating	the	arterial	function.	
CGRP	is	a	37-amino	acid	neuropeptide	that	has	two	major	forms	(α	and	β).	αCGRP	is	
primarily	 localized	 in	 the	 perivascular	 innervation	 and	 considered	 to	 be	 the	 major	
vascular	form,	as	compared	with	the	β	form.	This	peptide	usually	binds	to	a	calcitonin-
like	 receptor	 (CLR)	 that	 is	 linked	 to	 the	 Receptor	 Activity	Modifying	 Protein	 (RAMP)	
which	is	necessary	for	increasing	cyclic	adenosine	monophosphate	(cAMP)	production	
via	the	adenylate	cyclase	(AC)	[20]	and	may	therefore	lead	to	protein	kinase	A	(PKA)-
mediated	activation	of	K+	channels	in	VSMC	and	consequent	hyperpolarization.		αCGRP	
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can	 also	 control	 the	 expression	 of	 the	 mitogen-activated	 protein	 kinases	 (MAPK)	
pathway	and	inducible	nitric	oxide	synthase	(iNOS)	[21].	
	
 
Figure	1.4.	Long	and	short	reflexes	in	sensory	nervous	system.	In	long-term	reflexes,	the	sensory	
neurons	send	the	information	to	the	CNS	where	is	processed	and	then	send	it	to	the	peripheral	
effector.	 In	 short	 reflexes,	 the	 sensory	 neurons	 synapse	 directly	 with	 a	 peripheral	 effector	
generating	the	response.		
1.2.2.2	Role	of	sensory	nervous	system	in	vascular	function	
Sensory	 neurons	 have	 a	 physiological	 role	 in	maintaining	 vascular	 homeostasis	 [22].	
Although	CGRP	does	not	play	a	primary	role	in	the	regulation	of	basal	blood	pressure	in	
normal	individuals	[23,	24],	it	is	suggested	to	have	protective	roles	that	are	important	
for	physiological	and	pathological	conditions	in	the	vascular	system	[25].	These	include	
attenuation	 of	 VSM	 proliferation	 [26],	 hyperplasia	 [27,	 28]	 and	 stimulation	 of	
endothelial	cell	proliferation	and	endothelial	progenitor	cells	[29].	
The	SPNS	is	involved	in	some	neurovascular	syndromes	such	as	migraine.	Several	studies	
have	reported	that	SP	and	CGRP	are	released	in	this	neuronal	disorder	[30]	leading	to	a	
robust	dilation	of	 cranial	blood	vessels	 [31].	Moreover,	application	of	CGRP	 receptor	
antagonist	 in	 acute	migraine	has	been	 shown	 to	attenuate	CGRP-induced	dilation	of	
human	isolated	coronary	arteries	[32,	33].	
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Increased	levels	of	CGRP	have	been	also	reported	in	cardiac	failure	and	hypertension.	
However,	 there	 is	 evidence	 that	 an	 increase	 of	 CGRP	 is	 beneficial	 in	 preventing	
cardiovascular	diseases	associated	with	hypertension	[22].	In	fact,	mice	lacking	a-CGRP	
develop	significant	hypertension,	suggesting	a	protective	role	of	the	neurotransmitter	
in	the	vascular	disease	[34].	
1.3	The	vascular	tone		
The	 vascular	 tone	 is	 determined	 by	 the	 contractile	 activity	 of	 VSMC	 in	 the	 walls	 of	
resistance	 arteries,	which	 regulates	 the	 caliber	 of	 the	 vessel,	 and	 hence	 blood	 flow.	
According	to	Poiseuille’s	law,	resistance	is	directly	proportional	to	fluid	viscosity	ƿ	and	
tube	length	L	and	is	inversely	proportional	to	vessel	radius.	Thus,	small	changes	in	the	
diameter	of	these	small	vessels	lead	to	dramatic	changes	in	resistance	(Eq.	1.1).		
 𝑅 = 	 $%&'()                                                               (Eq.	1.1) 
	
Equation	1.	Poiseuille’s	law,	where	R	is	resistance	to	flow,	ƿ	refers	to	the	viscosity,	L	is	the	length	
and	r	corresponds	to	the	radius	of	the	artery.	
	
The	regulation	of	the	contractile	state	of	VSMC	is	dependent	on	a	complex	interplay	of	
vasodilator	 and	 vasoconstrictor	 stimuli	 from	 intrinsic	 and	 extrinsic	 processes,	 which	
implicates	the	circulation	of	hormones,	endothelial	secretions,	neurotransmitter	release	
and	the	modulation	of	physical	factors	such	as	the	blood	flow	and	the	tension	of	the	
vessel	wall [35].	All	these	signals	are	integrated	by	VSMC	to	determine	the	degree	of	
contraction	and	hence	the	diameter	of	the	blood	vessel.		
Among	the	intrinsic	mechanisms,	the	myogenic	response	is	a	fundamental	process	for	
the	 development	 of	 resting	 vascular	 tone,	 allowing	 a	 constant	 blood	 flow	 despite	
changes	in	arterial	pressure.	This	phenomenon	is	mediated	by	depolarization	attributed	
to	 activation	 of	 non-selective	 cationic	 channels	 increasing	 the	 intracellular	 Ca2+	 that	
would	 finally	 activate	 voltage-dependent	 Ca2+	 channels	 (VDCC),	 leading	 to	 the	
contraction	 of	 the	 artery.	 Other	 important	 intrinsic	 factors	 are	 the	 endothelial	
secretions	such	as	the	vasoconstrictor	endothelin	and	the	vasodilator	NO [1].		
On	the	other	hand,	the	extrinsic	mechanism	is	also	a	fundamental	control	system	of	the	
TPR	 and	 is	 mainly	 regulated	 by	 endocrine	 factors	 and	 the	 perivascular	 nerves	 that	
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innervate	 the	 resistance	arteries	 (Figure	1.5).	Non-selective	channels	present	 in	both	
sympathetic	 and	 sensory	 perivascular	 nerves	would	 be	 activated	 by	 external	 stimuli	
leading	 to	 an	 increase	 in	 cytosolic	 Ca2+	 concentration	 within	 the	 neuron	 and	
consequently	the	release	of	NTs.	These	NTs	can	in	turn	activate	their	receptors	on	the	
VSMC	and	endothelial	membrane	resulting	in	the	contraction	or	dilation	of	the	blood	
vessel.		
 
Figure	 1.5.	 Overview	 of	 vascular	 control.	 Vascular	 tone	 is	 determined	 by	 many	 different	
competing	vasoconstrictor	and	vasodilator	influences	acting	on	the	blood	vessel	(modified	from	
Levick	J.R.,	2003)	
	
Among	the	non-selective	channels,	Transient	Receptor	Potential	 (TRP)	channels	have	
been	proposed	as	molecular	sensors	involved	in	different	vascular	functions	in	response	
to	diverse	external	stimuli	playing	important	roles	in	the	control	of	the	TPR	[36-40].	TRP	
channels	are	not	only	expressed	in	VSMC	[41]	but	also	in	the	perivascular	nerves,	where	
they	contribute	to	cellular	excitability	[41-44].	
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1.4	Transient	Receptor	Potential	channels	
The	 TRP	 proteins	 constitute	 a	 large	 family	 of	 non-selective	 channels	 permeable	 to	
monovalent	and	divalent	cations	[45].	They	are	related	to	the	product	of	the	transient	
receptor	 potential	 (trp)	 gene	 in	 the	 fruit	 fly	 Drosophila	 melanogaster,	 where	 the	
founding	member	was	discovered	[46,	47].	The	28	mammalian	TRP	proteins	are	split	
into	 six	 subfamilies	 according	 to	 their	 amino	 acid	 sequence	 homology:	 TRPC1-7	
(Canonical),	 TRPM1-8	 (Melastatin),	 TRPV1-6	 (Vanilloid),	 TRPA1	 (Ankyrin),	 TRPML1-3	
(MucoLipin),	and	TRPP2,3	and	5	(Polycystin)	[48,	49]	(Figure	1.6).		
 
 
Figure	1.6.	Phylogenetic	tree	of	the	TRP	family	of	cation	channels	showing	the	classification	into	
six	subfamilies:	TRPA	(Ankyrin),	TRPP	(Polycystin),	TRPM	(Melastatin),	TRPC	(Canonical),	TRPML	
(MucoLipin)	and	TRPV	(Vanilloid)	(Nillius,	B.	et	al,	2011)	
Until	now,	only	the	structures	of	TRPA1,	TRPC4,	TRPC3,	TRPC6,	TRPM2,	TRPM4,	TRPM7,	
TRPM8	(Figure	1.7	B),	TRPV1,	TRPV2,	TRPV4	and	TRPV6	channels	have	been	determined	
by	 Cryo-electron	 microscopy	 [50-53].	 All	 TRP	 channels,	 comprise	 a	 homo	 or	
heterotetramer	of	TRP	proteins,	each	with	six	putative	transmembrane	segments	with	
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a	loop	between	S5	and	S6	forming	the	pore	of	the	channel	[54,	55].	Intracellular	amino	
and	 carboxyl	 termini	 are	 variable	 in	 length.	 The	 presence	 of	 ankyrin	 repeats,	 lipid-
interactions	 domains,	 EF	 hands	 and	 phosporylation	 sites	 in	 the	 amino	 termini	 can	
influence	channel	gating	[56,	57].	The	carboxyl	termini	are	very	variable	amongst	the	
different	TRP	protein	containing	calmodulin	binding	sites	and	entire	enzymatic	subunits	
[58,	59]	(Figure	1.7A).			
 
	
Figure	 1.7.	 Topological	 structure	 of	 TRP	 channels	 and	 Cryo-EM	 reconstruction	 of	 TRPM8	
channel.	(A)	TRP	channel	monomer	have	six	transmembrane	topology	(S1-S6)	with	a	pore	loop	
between	S5	and	S6.	The	cytoplasmic	N-	and	C-	termini	contain	different	structural	and	functional	
elements	as	indicated	for	each	subfamily.	Some	of	the	sensory	TRP	channels	such	as	TRPA1	and	
TRPV	family	contain	multiple	ankyrin	repeats	at	their	amino	termini	while	TRPM	family	contain	
a	 homology	 región	 (modified	 from	 Clapham,	 D.E.,	 2003).	 (B)	Cryo-EM	 reconstruction	 of	 the	
TRPM8	channel	(Yin	et	al.,	2018). 
TRP	channels	are	ubiquitously	expressed	in	a	variety	of	tissues	and	mammalian	cells	and	
most	 of	 them	 are	 localized	 in	 the	 plasma	 membrane	 [59].	 These	 channels	 can	 be	
activated	 by	multiple	 stimuli	 ranging	 from	 endogenous	 and	 exogenous	 chemicals	 to	
physical	 stimuli	 such	as	membrane	deformation	and	changes	 in	membrane	potential	
and	temperature.	The	activation	of	these	channels	leads	to	the	pore	opening	allowing	a	
cation	 influx	 and	 depolarization	 of	 the	 cell	 at	 the	 resting	 potential	 triggering	 the	
activation	of	VDCC	and	resulting	in	Ca2+	entry	to	the	cell	[49,	60].	The	increase	of	free	
cytosolic	 Ca2+	 concentration	 by	 TRP	 activation	 can	 modulate	 different	 downstream	
A B 
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cellular	 mechanisms	 [59].	 For	 instance,	 TRP	 proteins	 are	 essential	 for	 physiological	
processes	 including	 Ca2+	 and	 Mg2+	 homeostasis,	 the	 regulation	 of	 smooth	 muscle	
contraction,	 cell	 proliferation,	 migration,	 thermo-,	 chemo-	 and	 mechano-sensation	
processes	and	remodelling	in	pathological	conditions	[61-66].		
Several	members	of	 the	TRP	protein	 family	 including	TRPA1,	TRPM3,	TRPM8,	TRPV1,	
TRPV2,	TRPV3	and	TRPV4	have	been	 identified	as	 sensory	TRP	channels	due	 to	 their	
chemo-,	thermo-	and	mechano-sensory	properties	and	reported	to	be	expressed	mainly	
in	sensory	nerve	fibres	[67].	They	play	important	roles	in	neuropeptide	exocytosis	[68],	
vascular	physiology [69],	pain	sensation	[70,	71],	inflammatory	processes	[72,	73]	and		
thermoregulation	[62,	74,	75].		
1.5	Sensory	TRP	channels	in	the	vascular	system		
TRPA1,	 TRPV1,	 TRPM3,	 TRPM8	 and	 other	 TRP	 channels	 have	 been	 proposed	 as	
molecular	 sensors	modulating	 vascular	 functions	 [76-80].	 This	 thesis	 focuses	 in	 the	
arterial	 function	 of	 several	 sensory	 TRP	 cation	 channels	 in	 responses	 to	 external	
chemical	and	thermal	stimuli.	
Sensory	 TRP	 channels	 are	 involved	 in	 a	 variety	 of	 vascular	 functions,	 not	 only	 in	
modulation	 of	 VSMC	 contraction,	 but	 also	 in	 myogenic	 responses	 and	 Ca2+-induced	
VSMC	proliferation	and	migration	[81,	82].	Although	they	have	been	identified	in	the	
vascular	 system,	 where	 they	 are	 expressed	 in	 endothelium,	 VSMC	 and	 perivascular	
nerve	endings	innervating	the	arteries,	there	are	substantial	discrepancies	about	their	
vascular	functions	in	response	to	external	stimuli.	
1.5.1	TRPA1	
TRPA1	is	the	sole	member	of	the	mammalian	TRPA	family [83].	It	is	a	voltage-dependent	
nonselective	 cation	 channel	 permeable	 to	 Ca2+,	Na+	 and	 K+,	 and	 is	 considered	 as	 a	
sensor	of	mechanical,	chemical	and	noxious	thermal	stimuli.	TRPA1	can	be	activated	
by	 a	 wide	 range	 of	 endogenous	 pungent	 and	 external	 irritants	 that	 trigger	
inflammatory	processes	 and	pain	 [78,	 84-86].	Noxious	 compounds	 such	 as	 acrolein 
[78],	 allyl	 isothiocyanate [77]	 and	 cinnamaldehyde	 [87]	 are	 able	 to	 activate	 TRPA1	
through	 covalent	 modification	 of	 N-terminal	 cysteines	 or	 lysines.	 TRPA1	 is	 also	
activated	by	 the	 reactive	compounds	hypochlorite,	hydrogen	peroxide	and	NO	 [88-
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90].	Several	studies	have	shown	that	TRPA1	is	activated	by	cold	in	a	noxious	range [87,	
91-93]	and	that	they	coexpressed	with	nociceptors	markers	such	as	CGRP	and	SP [91].	
Other	reports	did	not	find	evidence	for	activation	of	TRPA1	by	cold [77,	94,	95].		
The	role	of	TRPA1	 in	 the	vascular	 system	 is	not	well-understood	yet.	Deletion	of	 the	
Trpa1	 gene	 in	mice	had	no	effect	on	blood	pressure	under	baseline	 conditions	or	 in	
response	 to	 angiotensin	 II [96].	Vascular	 expression	of	Trpa1	 is	 not	well	 determined	
although	it	was	demonstrated	to	be	expressed	in	many	different	layers	of	the	arteries	
[91,	 97,	 98].	 TRPA1	present	 in	 the	endothelium	of	 cerebral	 arteries,	 is	 concentrated	
within	 myoendothelial	 junction	 sites,	 where	 its	 activation	 mediates	 endothelium-
dependent	SMC	hyperpolarization	and	vasodilatation	that	requires	the	activity	of	Ca2+-
activated	K+	channels	 [99,	 100].	 TRPA1	 is	 activated	by	 lipid	 peroxidation	metabolites	
generated	by	reactive	oxygen	species	(ROS)	and	involved	in	the	ROS	signaling	pathway	
that	causes	endothelium-dependent	vasodilation [101].	
Many	studies	have	revealed	that	TRPA1	channels	are	expressed	in	sensory	perivascular	
nerves	[100,	102]	where	they	mediate	vasodilatation	of	peripheral	arteries	in	response	
to	chemical	agonists	through	the	release	of	CGRP	[103].	Yanaga	et	al.	demonstrated	a	
cinnamaldehyde-induce	dilation	in	precontrated	aortic	rings	that	was	not	abolished	in	
endothelium-denuded	 samples	 [104],	 suggesting	 a	 TRPA1-independent	 effect	 of	
cinnamaldehyde	[105].		
1.5.2	TRPV1	
TRPV1	is	a	polymodal	channel	that	can	be	activated	by	a	variety	of	chemical	and	physical	
stimuli	 [106]	 including	 capsaicin	 [107],	 resiniferatoxin	 [107],	 low	 pH	 [108],	
endocannabinoid	 lipids	 [108],	 heat	 [107]	 and	membrane	 depolarization	 [109].	 This	
channel	can	be	sensitized	by	the	activation	of	PKA	and	pro-inflammatory	mediators	such	
as	histamine	and	chemokines	[110].	TRPV1	is	the	first	channel	describe	to	be	activated	
by	heat.	The	burning	sensation	of	capsaicin	suggested	that	heat	and	capsaicin	could	act	
through	 the	 same	molecular	 pathway.	 Interestingly,	 a	 study	 revealed	 that	 TRPV1	 is	
mainly	expressed	in	peptidergic	primary	sensory	neurons	and	its	activation	resulted	in	
warm	 temperature	 and	 capsaicin-induced	 activation	 [107].	 In	 fact,	 cultured	 sensory	
neurons	 from	 TRPV1-deficient	 mice	 showed	 a	 lack	 of	 heat-induced	 currents	 upon	
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warming	 up	 to	 43	 oC,	 although	 higher	 heat-induced	 responses	 (>	 55	 oC)	 remained	
unchanged [76,	111].	
TRPV1	is	heterogeneously	expressed	across	VSM	of	blood	vessels	[112]	and	is	regulated	
at	the	level	of	the	individual	blood	vessels:	some	blood	vessels	showed	intense	TRPV1	
immunostaining,	whereas	nearby	vessels	were	negative	[112]. It	has	been	reported	that	
activation	of	TRPV1	expressed	in	rat	aortic	myocytes	by	capsaicin	causes	endothelium-
independent	vasoconstriction	[113].	This	was	supported	by	another	study	showing	that	
capsaicin	increased	Ca2+	uptake	of	VSMC,	resulting	in	vasoconstriction	[114].	
In	contrast,	numerous	authors	have	demonstrated	the	involvement	of	TRPV1	channels	
in	 the	 regulation	 of	 vascular	 tone	 in	 an	 endothelium-dependent	 manner	 [115-117].	
Yang,	D.	et	al.	showed	that	acute	administration	of	capsaicin	for	6	months	enhanced	the	
production	 of	 NO	 and	 endothelium-dependent	 relaxation	 in	 the	 isolated	mesenteric	
arteries	 from	 normal	 mice,	 an	 effect	 that	 was	 absent	 in	 Trpv1	 KO	 mice	 [118].	
Furthermore,	capsaicin	also	attenuated	the	contractile	response	of	thoracic	aortic	rings	
preconstricted	with	NA	[119].	Importantly,	immunohistochemical	analysis	identified	the	
expression	 of	 TRPV1,	 SP,	 and	 CGRP	 in	 sensory	 neurons	 innervating	 the	 resistance	
arteries	where	its	activation	can	trigger	vasodilation	via	CGRP	release	[120,	121].	
1.5.3	TRPM3	
The	Trpm3	gene	consist	of	28	exons	and	possesses	several	alternative	splice	sites	[122,	
123],	 which	 results	 in	 different	 isoforms	 [124]	 whose	 functions	 are	 still	 largely	
unexplored.	TRPM3	 is	a	voltage-dependent,	non-selective	cation	channel	 that	can	be	
activated	by	 intracellular	Mg2+	[123]	and	blocked	by	La3+	[124].	Stimulation	of	TRPM3	
typically	 induces	outwardly	rectifying	currents	and	the	single-channel	conductance	of	
the	 human	 TRPM3	 is	 65	 pS	 for	 isotonic	 Ca2+	 [125].	 TRPM3	 is	 reversibly	 activated	by	
hypotonic	cell	swelling	[125],	oxidative	stress	and	exposure	to	heat	[62,	126].	
Sphingolipids	 produced	 by	 the	 human	 body	 were	 the	 first	 TRPM3	 activators	 to	 be	
described	 [127].	 Another	 potent	 TRPM3	 activator	 is	 the	 neurosteroid	 pregnenolone	
sulfate	 (PS)	 which	 is	 able	 to	 induces	 rapid	 and	 reversible	 TRPM3	 activation,	 in	
overexpression	systems	and	 in	cells	endogenously	expressing	TRPM3	[128-131].	PS	 is	
produced	in	considerable	amounts	by	the	human	body	([PS]	in	plasma	»	100-800	nM),	
although	the	conditions	under	which	elevated	PS	levels	may	modulate	TRPM3	remain	
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unknown	 [132].	 TRPM3	 channels	 are	 expressed	 in	 mouse	 nociceptive	 neurons.	
Interestingly,	in	Trpm3-deficient	mice,	the	number	of	PS-sensitive	neurons	is	reduced.	
Intraplantar	injections	of	PS	in	the	paw	induced	nocifensive	behavioral	responses	that	
were	lacking	in	Trpm3	knockout	(KO)	mice	[62].	
Other	 related	substances	such	as	dehydorepiandrosterone	 (DHEA),	DHEA	sulfate	and	
pregnenolone	also	activates	TRPM3	but	with	a	low	efficacy	[130].	Furthermore,	other	
steroidal	analog	of	PS,	dehydroepiandrosterone	sulfate,	has	been	identified	to	activate	
TRPM3	channels	[133,	134].	
Nifedipine	 and	 1,4-dihydropyridine	 also	 activate	 TRPM3	 channels	 [130].	 It	 has	 been	
discussed	that	nifedipine	and	PS	act	on	TRPM3	in	different	biding-sites	causing	a	larger	
activation	of	TRPM3	channels	when	both	molecules	are	applied	[134].	Interestingly,	a	
new	synthetic	ligand	called	CIM0216	caused	a	potent	activation	of	TRPM3	[135].		
On	 the	 other	 hand,	 the	 first	 TRPM3	 inhibitors	 were	 troglitazone,	 pioglitazone	 and	
rosiglitazone	 [136].	 Other	 non-selective	 inhibitors	 of	 TRPM3	 are	 flufenamic	 acid,	
tolfenamic	acid	and	meclofenamic	acid	[131].	Some	of	the	most	potent	TRPM3	inhibitors	
described	so	far	are	natural	compounds	including	liquiritigenin	and	isosakuranetin	[137].	
Other	flavanones	such	as	hesperetin,	eriodictyol	and	naringenin	inhibit	TRPM3	currents	
in	freshly	isolated	DRG	neurons	[129].	Application	of	these	TRPM3	inhibitors	reduced	
the	 sensitivity	 of	mice	 to	 PS-induced	 pain.	 The	 deoxybezoin	 ononetin	 has	 been	 also	
identified	as	a	potent	TRPM3	blocker	[129,	136].		
TRPM3	 channels	 can	be	partially	 inhibited	by	 cholesterol	 and	other	 steroids	 such	 as	
progesterone,	 pregnanolone,	 estradiol,	 dihydrotestosterone	 and	 21OH-progesterone	
[128].	 However,	 the	 physiological	 relevance	 of	 these	 inhibitors	 on	 endogenously	
expressed	 TRPM3	 is	 not	 yet	 known.	 Currents	 mediated	 by	 TRPM3	 are	 inhibited	 by	
several	 synthetic	 compounds	 such	as	 the	nonsteroidal	diclofenac,	 the	anticonvulsant	
primidone	 and	 by	 the	 polyclonal	 antibody	 TM3E3 [128,	 138,	 139].	 Nonspecific	
compounds	can	also	inhibit	TRPM3	such	as	2-APB	[140]	and	the	lanthanides	Gd3+	and	
La3+	[125,	127].	
TRPM3	expressed	in	a	subset	of	sensory	neurons,	is	also	involved	in	noxious	heat	sensing	
since	these	heat-sensitive	neurons	are	reduced	in	Trpm3-deficient	mice.	Trpm3	KO	mice	
exhibited	 deficits	 in	 their	 responses	 to	 noxious	 heat	 as	 it	 was	 demonstrated	 by	
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prolonged	reaction	latencies	in	the	tail	immersion	and	hot	plate	assays	and	a	reduced	
avoidance	of	warm	areas	in	the	thermal	gradient	and	thermal	preference	tests	[62].		
Systematic	 expression	 analyses	 of	 human	 and	 mouse	 TRPM3	 channels	 in	 different	
tissues	by	quantitative	real	time	polymerase	chain	reaction	(qPCR)	indicated	a	high	level	
of	Trpm3	mRNA	in	the	brain,	sensory	neurons,	kidney,	and	adipose	tissue	[62,	125,	141-
143].	In	addition,	there	is	abundance	of	Trpm3	transcripts	in	other	tissues	such	as	sperm	
cells,	pancreas,	heart,	bladder	and	blood	vessels	[97,	128,	144-146].	
A	study	by	Naylor	et	al.	demonstrated	that	functional	TRPM3	channels	are	expressed	in	
VSMC	of	human	saphenous	veins	and	mouse	aorta	by	using	TRPM3-specific	antibody	
and	 siRNA	 [147].	Moreover,	 another	 study	 from	 the	 same	 group	 indicated	 potential	
functional	value	of	TRPM3	in	proliferating	and	contraction	in	VSMC	[128,	148].	
1.5.4	TRPM8	
TRPM8	is	a	non-selective	cation	channel	expressed	in	sensory	neurons	[149].	It	is	well	
known	to	be	activated	by	cold	 temperatures	and	by	chemical	compounds	 including	
menthol,	icilin,	and	several	inflammatory	agents	[63,	150-152].	A	phosphatidylinositol	
4,5-bisphosphate	 (PIP2)-related	mechanism	 has	 been	 proposed	 for	 the	 activation	 of	
TRPM8.	 Activation	 of	 Ca2+-dependent	 phospholipase	 C	 (PLC)	 shifts	 the	 voltage	
dependence	 of	 TRPM8	 channel	 curve	 to	 more	 positive	 potentials	 and	 reduces	 the	
channel	sensitivity	to	ligands	such	as	menthol	[153].	
Other	stimuli,	such	as	oxidative	stress [154]	and	the	synthetic	agonists	such	as	cryosim-
3	 (1-diisopropylphosphorylnonane)	 selectively	 activates	 TRPM8	 [155].	 On	 the	 other	
hand,	novel	 synthetic	 compounds	have	been	 reported	 to	block	TRPM8	channels,	 for	
instance	 RQ-00434739 [156],	 AMTB [157],	 KPR-2579	 [158],	 as	 well	 as	 the	menthol-
derivate	compound	menthoxypropanediol	[159].	
It	 is	 known	 that	 TRPM8	plays	 a	 role	 in	 regulation	 of	 the	 vascular	 tone	 since	 it	 can	
stimulate	both	vasoconstriction	and	vasodilation	processes	depending	on	the	previous	
vasomotor	tone	of	the	blood	vessel	[160].	A	single	study	showed	that	Trpm8	mRNA	is	
present	 in	 rat	aortic,	mesenteric,	 tail	and	 femoral	arteries	 [160]	and	 its	activation	by	
menthol	led	to	dilatory	responses.	However,	in	some	cases	menthol	caused	contractions	
of	endothelium-denuded	aortic	samples.	The	cooling	sensation	that	menthol	causes	in	
the	human	skin	has	been	associated	with	an	increased	blood	flow	in	the	skin	[161].	In	
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contrast,	Sun	et	al.	have	found	that	activation	of	TRPM8	attenuated	vasoconstriction	
of	 the	 mesenteric	 artery	 and	 lowered	 blood	 pressure	 via	 a	 RhoA/Rho	 kinase	
mechanism	[162].	Therefore,	the	exact	role	of	TRPM8	channels	in	the	vascular	system	
remains	unclear. 
1.5.5	Other	sensory	TRP	channels	
Other	TRP	channels	such	as	TRPV2	have	been	proposed	to	play	an	important	role	in	the	
stretch-activated	cation	currents	and	myogenic	constriction	in	retinal	arterioles [163].	
Activation	 of	 TRPV3	 channels	 seems	 to	 promote	 Ca2+	 influx	 and	 elicit	 endothelium-
dependent	dilation	of	cerebral	parenchymal	arterioles	[164].	In	uterine	radial	arteries,	
TRPV3	 caused	 an	 endothelium-independent	 IKCa-mediated	 dilation	 via	 the	 NO-PKG	
pathway [165].	 Furthermore,	 carvacrol,	 a	 TRPV3	 agonist	 found	 in	 oregan,	 elicits	
endothelium-dependent	vasodilation	[166].	
TRPV4	channels	have	been	implicated	as	mediators	of	Ca2+	influx	in	both	EC	and	VSMC	
[167].	 The	 activation	 of	 endothelial	 TRPV4	 channels	 led	 to	 endothelium-dependent	
vasodilation.	However,	very	 little	 is	known	about	 the	 functional	 role	of	TRPV4	 in	 the	
resistance	 vasculature	 or	 how	 these	 channels	 influence	 hemodynamic	 properties.	
Several	studies	have	found	that	activation	of	TRPV4	channels	produces	vasodilation	of	
VSMC	 [168].	 The	 presence	 of	 TRPV4	 in	 cerebral	 VSMC	 has	 been	 demonstrated	 by	
immunohistochemistry	 and	 RT-PCR [167]. Furthermore,	 super-resolution	 imaging	
reveals	 clustering	 of	 TRPV4	 channels	 in	 arterial	 myocytes	 [169].	 Using	
microspectrofluorimetry	and	patch-clamp,	Ducret	et	al.	 found	that	serotonin	 induced	
activation	 of	 TRPV4-like	 current	 followed	 by	 a	 sustained	 Ca2+	 entry	 resulting	 in	 an	
increased	of	VSM	proliferation [170]. In	addition,	TRPV4	channels	can	also	functionally	
interact	with	other	proteins.	For	instance,	activation	of	TRPV4–TRPC1–KCa1.1	complex	
by	 epoxyeicosatrienoic	 acids	 in	 human	 internal	 mammary	 arteries	 induced	 VSM	
membrane	hyperpolarization	followed	by	relaxation	[171].			
Introduction 1 
 
 21 
1.6	Modulation	of	vascular	function	by	thermal	stimuli:	role	of	
sensory	TRP	channels	
The	 regulation	 of	 the	 vasculature	 in	 response	 to	 thermal	 stimuli	 is	 a	 fundamental	
homeostatic	function	in	animals	that	is	critical	for	survival.	In	fact,	the	control	of	body	
temperature	is	the	main	factor	regulating	blood	flow	in	the	cutaneous	circulation.	The	
cutaneous	circulation	is	a	good	example	of	extrinsic	regulation,	as	the	tone	of	cutaneous	
vessels	is	under	the	control	of	the	sympathetic	nerves.	Under	basal	conditions,	there	is	
an	increased	sympathetic	tone	and	a	vasoconstriction	of	the	skin	vessels,	that	can	be	
accentuated	in	response	to	a	decrease	in	environmental	temperature,	as	a	mechanism	
to	minimize	heat	loss	through	the	skin.	The	blood	vessels	subsequently	dilate	to	restore	
blood	flow	for	protection	and	survival.	This	basic	adaptive	physiological	mechanism	of	
vasoconstriction	followed	by	vasodilation	was	first	described	by	Thomas	Lewis	[172].	
Conversely,	 increases	 in	 either	 body	 temperature	 or	 external	 temperature	 lead	 to	
vasodilation	by	inhibiting	the	tonic	activity	of	sympathetic	nerves,	allowing	blood	flow	
increased	to	the	cutaneous	territories	as	a	mechanism	to	dissipate	heat.	So,	the	systemic	
response	 against	 changes	 in	 external	 temperature	 is	mainly	 governed	 by	 peripheral	
nerves	fibres	connected	to	the	CNS.	This	central	system	integrates	temperature	changes	
and	generates	efferent	responses	to	adjust	heat-exchange	rates	with	the	environment	
[173,	174].	In	addition,	peripheral	nerves	are	also	capable	to	induce	fast	vasoconstrictor	
or	vasodilator	effect	in	the	cutaneous	circulation	in	response	to	temperature	changes	as	
a	protective	mechanism	[37].	
Often,	 body	 cooling	 raises	 sympathetic	 vasoconstrictor	 activity	 through	 reflexes	
initiated	by	low	temperature	[175].	However,	mammals	often	respond	to	maintained	
cool	 temperatures	 with	 a	 recovery	 vasodilatation	 (the	 “paradoxical	 vasodilation”	
mentioned	before)	and	this	is	associated	with	a	healthy	peripheral	vasculature	[176].	In	
fact,	a	loss	of	cold-induced	reflex	recovery,	associated	with	vasodilatation,	is	a	marker	
of	peripheral	vascular	diseases	such	as	Raynaud’s	disease	[177].		
The	contribution	of	the	sympathetic	tone	to	the	control	of	the	vasodilator	mechanisms	
in	 response	 to	 temperature	 changes	 in	 the	 cutaneous	 circulation	 is	well	 established	
[178].	 However,	 the	 molecular	 mechanisms	 behind	 these	 vascular	 reflexes	 are	 still	
unknown	and	even	the	thermosensitive	components	remain	unclear.	Since	some	non-
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selective	cation	channels	of	the	TRP	family	expressed	in	sensory	neurons	and	other	cells	
work	as	thermosensors	being	activated	by	changes	in	ambient	temperature	(Figure	1.8),	
there	is	strong	evidence	suggesting	that	sensory	TRP	channels,	including	TRPA1,	TRPM8,	
TRPV1	 and	 other	 TRP	 channels	 are	 also	 relevant	 in	 the	 local	 vascular	 responses	 to	
thermal	changes	[179].	
The	molecular	sensors	responsible	for	the	detection	of	cold	are	sill	unclear.	However,	
TRPA1	 is	 a	 controversial	 candidate	 in	 the	 cold-induced	 vascular	 pathway [180].	 This	
controversy	has	not	been	yet	resolved	by	the	use	of	Trpa1-deficient	mice	in	behavioral	
studies.	While	some	studies	found	reduced	noxious	cold	sensing	in	Trpa1	KO	mice	[181-
184]	others	showed	normal	responses	[78,	185]	or	only	reduced	cold	responses	when	
TRPA1	 sensitivity	 is	 enhanced	 by	 exogenous	 agonists	 [186].	 In	 addition,	 one	 study	
demonstrated	that	human	TRPA1	could	act	as	a	bidirectional	thermosensor	depending	
on	the	presence	of	 ligands	contributing	to	both	heat	and	cold	sensation	[187].	Other	
studies	using	pharmacological	blockade	of	TRPA1	in	mice	have	shown	that	TRPA1	is	not	
involved	in	mediating	cold	responses	[188,	189].		
	
 
Figure	1.8.	Frequencies	at	different	skin	temperatures	of	thermoreceptors,	along	with	potential	
transient	 receptor	 potential	 (TRP)	 channels	 associated	with	 receptor	 function	 (Tansey	et	 al.,	
2015).	
TRPA1	has	 also	been	proposed	as	 a	 vascular	 sensor [37].	 Cutaneous	blood	 flow	was	
reduced	using	cold	water	 immersion	of	an	anesthetized	mouse	paw.	Similar	vascular	
Introduction 1 
 
 23 
responses	were	found	in	wilt	type	mouse	paw	using	a	cold	copper	probe	but	not	in	Trpa1	
KO	mice.	These	results	suggested	that	the	two	cold	treatment	techniques	could	produce	
TRPA1-dependent	 vascular	 responses	 via	 different	 mechanisms [37].	 Furthermore,	
administration	of	TRPA1	antagonists	significantly	inhibited	the	vasoconstriction	induced	
by	 the	 cold-water	 immersion	 demonstrating	 the	 relevance	 of	 TRPA1	 in	 the	 vascular	
response.	 In	 accordance	with	 this,	 using	 a	 full-field	 laser	 perfusion	 imager	 in	 vivo	 to	
measure	cutaneous	blood	flow,	Aubdool	et	al.	found	that	TRPA1	is	essential,	not	only	in	
the	initial	vasoconstrictor	response	of	the	local	cold-induced	vascular	response	in	the	
physiological	reflex,	but	also	in	the	restorative	vasodilation	[190].	
Another	candidate	in	the	range	of	cold	temperature	is	TRPM8,	which	can	be	activated	
by	low	temperatures.	TRPM8	rather	than	TRPA1	is	considered	to	have	a	major	role	in	
the	 response	 to	 deep	 body	 cooling	 [191]	 and	 in	 cold-induced	 pain	 behaviors	 [192].	
Furthermore,	TRPM8	channels	are	activated	by	compounds	such	as	icilin	and	menthol	
that	induce	a	cooling	sensation	[193].	Interestingly,	intravenous	injections	of	menthol	
made	wild	type	rats	to	select	warmer	temperatures	in	a	thermal	gradient	 in	order	to	
maintain	the	core	body	temperature	constant	[194].	Several	groups	have	demonstrated	
using	Trpm8	KO	mice,	 that	 TRPM8	 are	 key	 channels	 responsible	 in	 the	 detection	 of	
external	cold	since	the	mutant	animal	did	not	respond	to	noxious	cold		[150,	152].	In	
another	study,	 it	was	 found	an	 increased	 latency	 for	withdrawal	 from	a	cold	plate	 in	
Trpm8-deficient	mice	compared	to	control	mice	[151].	In	addition,	menthol	application	
also	 triggered	 autonomic	 responses	 such	 as	 shivering	 and	 tail	 skin	 vasoconstriction	
[195].	TRPM8	channels	are	known	to	be	expressed	in	afferent	neurons	surrounding	the	
vasculature	where	they	can	modulate	vascular	responses	to	external	stimuli	 [160].	 In	
fact,	 it	was	reported	that	cold-induced	vasoconstriction	was	partially	but	significantly	
reduced	in	Trpm8	KO	mice	[190].	
The	 physiologic	 response	 of	 vasoconstriction	 under	 localized	 cooling	 was	 prevented	
upon	pharmacological	 blockade	of	 TRPA1	 and	 TRPM8	 channels	 suggesting	 that	 both	
channels	 are	 required	 to	 produce	 the	 cold-induced	 vascular	 response	 [37].	 Using	
Trpa1/Trpm8	double	KO	mice,	Pan	et	al.	 showed	a	 large	reduction	 in	cold	avoidance	
compared	 to	 that	 of	 single	 Trpm8	 KO	 mice,	 suggesting	 that	 both	 receptors	 work	
together	 in	 the	 detection	 of	 the	 entire	 cold	 temperature	 range [37].	 This	 further	
supports	 the	 findings	of	Winter	and	colleagues	 that	both	channels	 can	 influence	 the	
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vascular	cold	response	over	the	complete	cold	temperature	range	by	the	activity	of	cold-
activated	sensory	fibers,		resulting	in	a	synergistic	effect	[196].	However,	none	of	these	
studies	explore	the	direct	effect	of	thermal	changes	on	the	vasoconstrictor	response	of	
the	blood	vessel	or	the	expression	and	the	functional	contribution	of	these	channels	to	
the	cold-induced	vascular	responses.	
In	 the	warm	 temperature	 range,	 global	 Trpv1	KO	mice	 have	 revealed	 that	 TRPV1	 is	
involved	in	heat	sensation [197].	Application	of	TRPV1	agonists	such	as	capsaicin,	which	
produces	 a	 hot	 sensation	 was	 found	 to	 decrease	 the	 basal	 temperature	 due	 to	
peripheral	vasodilation	[198].	In	addition,	capsaicin-induced	ablation	of	sensory	fibres	
and	sensitized	animals	to	heat	challenge	[199].	It	has	been	reported	that	antagonist	of	
TRPV1	induced	vasoconstriction	and	modulated	the	thermoregulatory	response	[200].	
Other	study	has	demonstrated	that	TRPV1	and	TRPV4	expressed	in	sensory	nerves	can	
modulate	the	vascular	function	under	warm	conditions	[201].	
Another	 TRP	 channel	 identified	 to	 be	 involved	 in	 noxious	 heat	 sensing	 is	 TRPM3	
expressed	 in	 sensory	 neurons	 [62].	 An	 increase	 in	 temperature	 to	 37	 oC	 caused	 a	
sensitization	of	TRPM3	to	PS,	and	it	has	been	postulated	that	even	the	physiological	PS	
concentration	 found	 in	 the	 human	 body	 is	 more	 than	 sufficient	 to	 activate	 TRPM3	
channels,	especially	at	that	temperature	[130,	133].	Importantly,	inhibition	of	TRPM3	by	
flavanones	reduced	the	sensitivity	of	mice	to	noxious	heat	[129].	TRPV2	channels	have	
been	 reported	 to	 be	 expressed	 in	 sensory	 neurons	 representing	 as	 candidates	 for	
noxious	heat	sensing.	Heterologous	expression	of	TRPV2	channels	produced	a	cation	
current	at	temperatures	above	52	oC	[202].	However,	Trpv2	KO	mice	did	not	show	any	
effect	 to	 noxious	 heat	 [203].	 Whether	 TRPM3	 and	 TRPV2	 channels	 are	 involved	 in	
vascular	responses	to	thermal	challenges	remains	still	unclear.	
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The	regulation	of	the	arterial	pressure	under	certain	stimuli	is	an	essential	physiological	
process	 determined	 by	 the	 balance	 of	 competing	 vasoconstrictor	 and	 vasodilator	
influences	acting	on	the	resistance	arteries.	Recent	studies	 indicate	that	sensory	TRP	
channels	expressed	in	the	vascular	system	can	be	activated	by	a	diverse	range	of	stimuli	
and	are	able	to	influence	cellular	excitability	and	intracellular	Ca2+	signaling	resulting	in	
their	implication	in	the	mechanisms	underlying	vascular	tone	regulation.	However,	their	
actual	 relevance	 in	 the	 vascular	 physiology	 in	 response	 to	 chemical	 and	 thermal	
challenges	remains	unknown.		
Considering	 these	 precedents	 and	 the	 fact	 that	 sensory	 TRP	 channels	 are	 highly	
expressed	 along	 the	 vascular	 system,	 we	 hypothesized	 that	 sensory	 TRP	 channels	
activity	may	influence	the	arterial	function	and	regulate	the	vascular	tone	of	resistance	
arteries	in	response	to	chemical	and	thermal	stimuli	under	physiological	conditions.	
In	order	to	address	this	hypothesis,	we	proposed	the	following	aims:	
1) To	determine	 the	expression	pattern	of	 transient	 receptor	melastatin	 (TRPM)	
family	 in	 mesenteric	 arteries	 and	 particularly	 the	 functional	 localization	 of	
TRPM3	 channels	 in	 the	 local	 control	 of	 vascular	 function	 by	 application	 of	
chemical	 stimuli.	 To	 address	 this	 objective,	 we	 performed	 qPCR,	 confocal	
imaging,	 Ca2+-imaging,	 pressure	 myography	 and	 patch	 clamp	 experiments	 in	
mesenteric	arteries	from	c57bl/6j	mice	and	Trpm3	KO	mice	as	control.		
2) To	determine	 the	possible	contribution	of	TRPA1	and	TRPM8	channels	 to	 the	
vascular	responses	to	local	cold	in	isolated	cutaneous	arteries.	The	role	of	both	
channels	in	cold-induced	systemic	reflexes	(involving	CNS	regulation)	has	been	
already	described	by	Aubdool	et	al. [190].	In	our	study,	we	investigate	if	isolated	
peripheral	 cutaneous	 arteries	 have	 an	 intrinsic	 cold-sensitivity	 and	 whether	
TRPA1	 and	 TRPM8	 channels	 contribute	 to	 this	 local	 response.	 For	 that,	 we	
performed	pressure	myography	 experiments	 in	 isolated	plantar	 arteries	 from	
c57bl/6j,	 Trpa1	 and	 Trpm8	 KO	mice	 to	 determine	 changes	 in	 diameter	 upon	
exposure	to	 low	temperature	and	to	explore	the	contribution	of	cold-induced	
activation	of	these	channels	to	the	vascular	responses.		
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3.1	Animals	
The	experiments	were	performed	on	c57bl/6j	(Janvier	Laboratories,	Berthevin	Cedex,	
France),	Trpm8	wild	type,	Trpm3	KO	(Lexicon	genetics;	MGI:3528836),	Trpv4	KO,	Trpa1	
KO [182]	 and	 Trpm8	KO	male	mice	 on	 a	 c57bl/6j	 background	 (Jackson	 laboratories,	
Maine,	USA)	[150],	weighing	about	25	g	and	from	10	to	12	weeks	of	age.	Mice	were	
housed	in	a	conventional	facility	on	a	12	h	light-dark	cycle	and	they	received	standard	
food	and	drinking	water	ad	libitum.	Animals	were	anesthetized	and	then	euthanized	by	
CO2	 inhalation.	All	 protocols	were	 in	 accordance	with	 the	 European	Community	 and	
Belgian	 Governmental	 guidelines	 for	 the	 use	 and	 care	 of	 experimental	 animals	
(2010/63/EU,	 CE	 Off	 Jn8L358,	 LA12110551)	 and	 approved	 by	 the	 KU	 Leuven	 Ethical	
Committee	Laboratory	Animals	(ECD)	and	the	Institutional	Care	and	Use	Committee	of	
the	University	of	Valladolid.		
3.2	Vascular	smooth	muscle	cells	isolation		
3.2.1	Surgery	
Mice	were	anesthetized	and	then	euthanized	by	CO2	inhalation.	Plantar	or	mesenteric	
arteries	 were	 isolated	 from	 each	 mouse.	 Subsequently,	 all	 samples	 were	 carefully	
dissected	 and	 cleaned	 from	 adipose	 tissue	 in	 cold	 oxygenated	 smooth	 muscle	
dissociation	 solution	 (SMDS)	 containing	 (in	mM):	 145	 NaCl,	 4.2	 KCl,	 0.6	 KH2PO4,	 1.2	
MgCl2,	 10	 HEPES,	 glucose	 11	 and	 10	 Ca2+	 (pH	 7.4,	 adjusted	 with	 NaOH).	 After	 the	
cleaning,	 they	were	processed	 in	different	ways	depending	on	their	 final	use:	 (1)	 the	
arteries	were	subjected	to	an	enzymatic	digestion	to	either	get	fresh	dispersed	VSMC	or	
for	 further	extract	RNA	or	 (2)	directly	used	to	carry	out	myography	experiments	and	
immunostaining	assays.	
3.2.2	Enzymatic	digestion	
The	 dissected	 arteries	were	 cut	 into	 small	 pieces	 and	 subjected	 to	 two	 consecutive	
processes	of	enzymatic	digestion.	The	first	digestion	was	carried	out	at	37	°C	for	15	min	
in	 SMDS-Ca2+-free	 solution	 containing	 0.8	 mg/ml	 papain	 (Worthington	 Biochemical	
Corp.),	 1	 mg/ml	 Bovine	 Serum	 Albumin	 (BSA)	 (Sigma-Aldrich),	 and	 1	 mg/ml	 1,4-
Dithioerythritol	(DTE)	(Sigma-Aldrich).	The	second	digestion	was	performed	at	37	°C	for	
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15	min	using	10	µM	Ca2+	SMDS	supplemented	with	0.6	mg/ml	 collagenase	F	 (Sigma-
Aldrich),	and	1	mg/ml	bovine	serum	albumin	 (BSA)	 (Sigma-Aldrich).	Digested	arteries	
were	 rinsed	 twice	with	 10	 μM	Ca2+	SMDS.	 After	 this	washing	 step,	 single	 cells	were	
obtained	 by	 mechanical	 disruption	 with	 a	 wide-bore	 glass	 pipette.	 Cells	 were	
maintained	at	4	°C	until	they	were	used	in	patch-clamp	recordings.	
3.3	Sympathetic	ganglia	isolation		
c57bl/6j	male	mice	were	anesthetized	and	then	euthanized	by	CO2	inhalation.	Cervical	
sympathetic	ganglia	were	isolated	from	the	sympathetic	chain.	Subsequently,	they	were	
carefully	cleaned	from	adipose	tissue	in	cold	oxygenated	SMDS	containing	10	µM	Ca2+.	
After	the	cleaning,	the	ganglia	were	subjected	to	RNA	extraction	procedure.	
3.4.	RNA	extraction	and	cDNA	synthesis	
Arteries	were	enzymatically	digested	as	described	in	section	3.2.2,	but	decreasing	the	
incubation	time	to	9	min	with	the	enzymes	and	skipping	the	washing	step	with	SMDS-
10	µM	Ca2+,	so	that	nerve	fibres,	smooth	muscle	and	endothelial	cells	were	still	present	
in	the	preparation.	Arteries	of	6	mice	were	used	for	each	determination.	Total	RNA	from	
the	 digested	 arteries	 or	 sympathetic	 ganglia	 was	 extracted	 using	 RNeasy	 mini	 kit	
(Qiagen),	following	manufacturer’s	protocol.	Once	RNA	was	purified,	quantification	and	
verification	of	their	quality	was	assessed	using	Experion	RNA	Stdsens	Analysis	kit	(Bio-
Rad),	samples	with	RNA	quality	 indicator	 (RQI)	values	below	8	were	discarded.	cDNA	
synthesis	was	performed	with	500	ng	of	total	RNA	using	Ready-to-go	First	strand	beads	
(GE	Healthcare)	 and	used	 for	quantitative	 real-time	polymerase	 chain	 reaction	 (qRT-
PCR).		
3.5	Quantitative	real-time	polymerase	chain	reaction		
A	small	fraction	of	the	cDNA	synthetized	was	used	for	qRT-	PCR.	qPCR	reactions	were	
performed	with	the	7500	Fast	Real-Time	PCR	System	(Life	Technologies)	by	incubating	
at	50	°C	for	2	min	and	95	°C	for	10	min,	then	40	cycles	of	95	°C	for	15	s	and	60	°C	for	1	
min. Each	qPCR	reaction	 (20	µl)	 contained	3	µl	of	 cDNA	template,	10	µl	of	Universal	
TaqMan	MasterMix	 (2x	 concentrated,	 Life	 Technologies),	 1	 µl	 of	 TaqMan	 assay	 (20x	
Materials and Methods 3 
 
 33 
concentrated,	Life	Technologies)	and	6	µl	H2O.	For	every	experiment,	test	reactions	were	
performed	in	triplicate,	and	non-template	negative	controls	(NTC)	in	duplicate.	 
Fluorescent	signals	generated	during	PCR	amplifications	were	normalized	to	an	internal	
reference	 selected	 between	 two	 potential	 housekeeping	 genes	 β-actin	 and	
glyceraldehyde-3P-dehydrogenase	 (GAPDH)	 for	 accurate	 quantification	 of	 interested	
gene	 expression	 levels	 in	 each	 sample.	 We	 used	 GAPDH	 as	 endogenous	 gene	 for	
representing	the	data.	The	threshold	cycle	(Ct)	was	set	within	the	exponential	phase,	
and	the	relative	quantitative	evaluation	of	target	gene	levels	was	performed	using	the	
2-∆Ct	 method.	 Differences	 between	 samples	 with	 and	 without	 endothelium	 were	
calculated	with	the	2-∆∆Ct	method,	using	the	samples	with	endothelium	as	the	calibrator	
(∆∆Ct	=	∆Ctwithout	-	∆Ctwith).		
3.6	Immunofluorescence	microscopy	
Intact	arteries	from	c57bl/6j	and	Trpm3	KO	mice	were	fixed	with	4%	paraformaldehyde	
(PFA)	in	phosphate-buffered	saline	(PBS)	for	15	min,	permeabilized	in	PBTx	(PBS,	0.2%	
Triton	X-100)	 and	blocked	with	PBTx	with	2%	of	 sheep	 serum	 for	3	h.	Arteries	were	
incubated	overnight	 at	 4	 °C	with	 the	primary	 rabbit	 anti-TRPM3	 (1:100,	 Santa	Cruz),	
mouse	anti-NF-200	(1:1000,	MFCD02263444,	sigma	Aldrich),	human	PGP9.5	antibody	
(1:100,	sc176636,	Santa	Cruz),	chicken	anti-beta-gal	IgY	(1:1000,	ab9361,	Abcam),	rabbit	
anti	 calcitonin	 gene-related	 peptide	 (1:500,	 ab47027,	 Abcam),	 mouse	 anti-tyrosine	
hydroxylase	 (1:1000,	 ab129991,	 Abcam)	 or	 rabbit	 anti-alpha	 smooth	 muscle	 actin	
(1:250,	 ab5694,	 Abcam)	 antibodies,	 followed	by	 the	 secondary	 antibodies	Alexa	 594	
goat	 anti-rabbit	 (1:1000,	 A-11012,	 Molecular	 Probes),	 Alexa	 555	 goat	 anti-mouse	
(1:1000,	ab150114,	Abcam),	Alexa	488	donkey	anti-chicken	(1:1000,	ab63507,	Abcam,	
Alexa	488	goat	anti-mouse	(1:1000,	ab150117,	Abcam)	or	goat	anti-chicken	IgY-Alexa	
488	 (1:1000,	 ab150173,	 Abcam).	 Secondary	 antibodies	 were	 prepared	 in	 blocking	
solution	 and	 incubated	 for	 2	 h	 at	 room	 temperature.	 Finally,	 the	 arteries	were	 flat-
mounted	in	glass	slides	using	DAPI-containing	mounting	solution	(VectaShield,	Vector	
Laboratories).		
Human	 Embryonic	 Kidney	 293	 (HEK293T)	 cells	 were	 plated	 in	 poly	 L-lysine-coated	
coverslips,	 fixed	with	4%	PFA	in	PBS	for	15	min	and	blocked	with	PBS	with	2%	sheep	
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serum	for	3	h.	The	cells	were	incubated	with	primary	antibody	rabbit	anti-TRPM3	(1:100,	
Santa	Cruz)	overnight	at	4	°C.	After	that,	samples	were	incubated	with	the	secondary	
antibody	 Alexa	 594	 goat	 anti-rabbit	 (1:1000,	Molecular	 Probes)	 in	 blocking	 solution	
during	 2	 h	 at	 22	 °C.	 The	 coverslips	 were	 mounted	 using	 DAPI-containing	 mounting	
solution	(VectaShield,	Vector	Laboratories).	
Confocal	images	of	labelled	cells	and	arteries	were	collected	using	the	optimal	pinhole	
size	for	the	Plan-Apochromat	63x/1.4	oil	objective	and	20x	or	40x	objective	of	a	Zeiss	
LSM	 510	 Meta	 Multiphoton	 microscope	 (Carl	 Zeiss	 AG).	 Images	 were	 acquired	 by	
consecutive	 excitation	 with	 Argon	 laser	 at	 488	 nm	 and	 He-Ne	 laser	 at	 543	 nm.	 For	
nuclear	DAPI	staining,	we	used	a	two-photon	pulsed	excitation	by	the	Spectra-Physics	
(Mountain	View)	Mai	Tai	laser	at	770	nm.	Images	were	analyzed	using	ImageJ	processing	
software.	The	z-position	in	the	single	plane	images	was	determined	after	ad-hoc	live	z-
scanning	of	nuclei,	according	to	the	clear	morphological	differences	between	adventitia	
(round	nuclei)	and	VSMC	nuclei	(elongated,	perpendicular	to	the	longitudinal	axis	of	the	
artery,	and	below	the	round	nuclei).	
3.7	Pressure	myography	experiments	
Third	order	mesenteric	and	plantar	arteries	(~200	µm)	were	dissected	and	mounted	in	
a	 myograph	 (Danish	 Myo	 Technology	 110P)	 that	 allowed	 controlling	 the	 luminal	
pressure	while	measuring	 external	 arterial	 diameter	 via	 digital	 video	 edge	 detection	
(CCD	 camera).	 Arterial	 segments	 were	 cannulated	 between	 two	 borosilicate	 glass	
pipettes	and	fixed	with	nylon	filaments	at	both	ends.	The	artery	segments	were	filled	
with	physiological	saline	solution	containing	(mM):	120	NaCl,	2.5	CaCl2,	1.17	MgSO4,	5	
KCl,	1.18	Na2HPO4,	25	NaHCO3,	1	EDTA,	10	glucose	(pH	7.4	adjusted	with	5%	CO2-95%	
air,	which	was	maintained	throughout	the	duration	of	the	experiment).	Arteries	were	
pressurized	 to	70	mmHg	and	allowed	 to	 stabilize	at	37	 °C	 for	at	 least	15	min	before	
starting	 the	 measurements.	 Unless	 otherwise	 stated	 the	 artery	 segments	 were	 air-
bubbled	though	the	lumen	to	remove	endothelial	cells.	Phenylephrine	(10	μM)	or	NA	
(20	 μM)	 were	 perfused	 to	 contract	 the	 arteries	 prior	 to	 the	 application	 of	 test	
compounds.	 PS	 and	 CIM	were	washed	 after	 their	 last	 application	with	 physiological	
saline	solution	containing	10	μM	phenylephrine.	The	data	were	analyzed	using	MyoView	
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software.	At	the	end	of	each	experiment,	we	applied	the	L-type	Ca2+	channel	blocker	
nifepidine	 (10	 μM)	 to	 determine	 the	 maximum	 arterial	 diameter.	 Vasodilation	 was	
determined	using	the	formula:		
𝑉𝑎𝑠𝑜𝑑𝑖𝑙𝑎𝑡𝑖𝑜𝑛	 𝑖𝑛	% = 	 100 ∗ 	 78	9	7:;<7=>?	9	7:;< 																				(Eq.	3.1)	
Dx,	DPhe	and	DNif	are	the	diameters	recorded	in	the	presence	of	test	compound	plus	
phenylephrine,	phenylephrine	alone	and	nifedipine,	 respectively.	 The	 resulting	dose-
response	 curves	 for	 the	 test	 compounds	 (X)	were	 fitted	using	either	one	or	 two	Hill	
functions	of	the	forms:	
																																					𝑉𝑎𝑠𝑜𝑑𝑖𝑙𝑎𝑡𝑖𝑜𝑛	(𝑖𝑛	%) = 100 [C]E[C]EFGE																																	(Eq.	3.2)	
were	 [X],	 n	 and	 k	 are	 the	 test	 compound	 concentration,	 the	Hill	 coefficient	 and	 the	
effective	concentration,	respectively,	and:	
𝑉𝑎𝑠𝑜𝑑𝑖𝑙𝑎𝑡𝑖𝑜𝑛	(𝑖𝑛	%) = 100 HI[C]EI[C]EIFGIEI + K9HI [C]EL[C]ELFGLEL 																					(Eq.	3.3)	
were	 A1,	 n1	 and	 k1	 are	 the	 relative	 amplitude,	 the	 Hill	 coefficient	 and	 the	 effective	
concentration	 of	 the	 first	 Hill	 component,	 respectively,	 and	 n2	 and	 k2	 are	 the	 Hill	
coefficient	and	the	effective	concentration	of	the	second	Hill	component,	respectively.	
In	the	cold	stimulus,	vasoconstriction	was	determined	using	the	formula:	
𝑉𝑎𝑠𝑜𝑐𝑜𝑛𝑠𝑡𝑟𝑖𝑐𝑡𝑖𝑜𝑛	 𝑖𝑛	% = 	− 100 ∗	 78	9	7:;<7=>?	9	7:;< 																							(Eq.	3.4)	
Dx,	DPhe	and	DNif	were	the	diameters	recorded	in	the	presence	of	cold	stimulus	and	
phenylephrine,	phenylephrine	alone	and	nifedipine,	 respectively.	A	maximum	of	 two	
arteries	was	taken	from	each	mouse.	In	those	cases,	the	data	were	averaged.	
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3.8	Intracellular	Ca2+	fluorescence	imaging		
Ca2+	 imaging	 experiments	were	 conducted	with	 the	 fluorescent	 indicator	 Fura-2AM.	
HEK293T	cells	stably	expressing	murine	TRPM3	were	cultured	as	previously	described	
[62].	 They	 were	 incubated	 with	 5	 μM	 Fura-2AM	 (Invitrogen)	 for	 30	 min	 at	 37	 °C.	
Fluorescence	 measurements	 were	 performed	 with	 a	 Zeiss	 Axioskop	 FS	 upright	
microscope	 fitted	 with	 an	 ORCA	 ER	 charge-coupled	 device	 camera.	 Fura-2AM	 was	
excited	 at	 340	 and	 380	 nm	with	 a	 rapid	 switching	monochromator	 (TILL	 Photonics).	
Mean	fluorescence	intensity	ratios	(F340/F380)	were	displayed	online	with	Metafluor	
software	(Molecular	Devices).	The	standard	extracellular	solution	contained	(in	mM)	
140	NaCl,	3	KCl,	2.4	CaCl2,	1.3	MgCl2,	10	HEPES	and	10	glucose	(pH7.4	adjusted	with	
NaOH).		
3.9	Patch-clamp	electrophysiology		
Whole-cell	patch-clamp	recordings	were	performed	in	freshly	 isolated	VSMC	at	22	°C	
using	an	Axopatch	200	patch-clamp	amplifier	 (Axon	 Instruments,	Molecular	Devices),	
filtered	at	2	kHz	(-3	dB,	four-pole	Bessel	filter),	and	sampling	at	10	kHz.	Recordings	were	
digitized	with	a	Digidata	1322A	 interface,	driven	by	CLAMPEX	10	(Axon	Instruments).	
Patch	pipettes	were	made	from	borosilicate	glass	(2.0	mm	O.D.,	WPI)	and	double	pulled	
(Narishige	PP-83)	to	resistances	ranging	from	2	to	5	MΩ	when	filled	with	the	internal	
solution.	For	Kv	channel	recordings,	the	composition	of	this	solution	was	(in	mM):	125	
KCl,	 4	 MgCl2,	 10	 Hepes,	 10	 EGTA,	 5	 Mg2+-ATP,	 pH	 7.2	 adjusted	 with	 KOH.	 The	
composition	of	the	bath	solution	was	(in	mM):	141	NaCl,	4.7	KCl,	1.2	MgCl2,	1.8	CaCl2,	
10	glucose,	10	Hepes	and	500	nM	paxilline,	pH	7.4	adjusted	with	NaOH.	The	voltage	
dependence	of	 total	K+	 current	was	obtained	applying	200	ms	pulses	 from	a	holding	
potential	of	-80	mV	to	voltages	between	-60	to	+60	mV	in	20	mV	steps	at	5	s	intervals.	
Whole-cell	patch-clamp	recordings	of	TRP	currents	were	carried	out	with	solutions	of	
the	following	composition	(in	mM):	141	NaCl,	1.8	CaCl2,	1.2	MgCl2,	5	CsCl,	10	glucose,	
10	HEPES,	0.005	nicardipine	(a	voltage-dependent	Ca2+	channel	antagonist),	0.1	DIDS	(an	
anion	 exchange	 inhibitor)	 and	 0.1	 niflumic	 acid	 (chloride	 channel	 inhibitor),	 pH	 7.4	
adjusted	with	NaOH	for	the	extracellular	solution	and	10	CsCl,	110	Cs	aspartate,	10	NaCl,	
3.2	CaCl2,	10	HEPES,	10	BAPTA,	2	Mg2+-ATP	(pH	7.2,	adjusted	with	CsOH)	and	with	an	
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estimated	free	[Ca2+]	of		̴100	nM	for	the	intracellular	solution.	To	determine	the	effects	
of	PS	(10	μM	and	30	μM),	CIM0216	(2	μM)	and	Uridine-5´-triphosphate	(UTP,	100	μM)	
currents	were	recording	upon	stimulation	with	1	s	voltage	ramps	from	-150	mV	to	+80	
mV	applied	from	a	holding	potential	of	-60	mV	at	5	s	intervals.	Electrophysiological	data	
analyses	were	performed	with	the	Clampfit	subroutine	of	pCLAMP	(Axon	Instruments)	
and	with	Origin	9	software	(OriginLab	Corp.).		
3.10	Reagents	
Pregnenolone	sulfate	(PS),	phenylephrine,	AngII,	nifedipine,	guanethidine	and	UTP	were	
purchased	 from	 Sigma-Aldrich.	 CIM0216	 was	 obtained	 from	 Prof.	 Joris	 Vriens	
(Department	 of	 Development	 and	 Regeneration,	 KU	 Leuven).	 The	 CGRP	 receptor	
antagonist	BIBN	4096	was	obtained	from	Tocris	Bioscience.	KV	channel	toxin	blockers,	
paxilline	and	stromatoxin,	were	dissolved	in	dimethyl	sulfoxide	(DMSO)	and	purchased	
from	Alomone	Laboratories.	Correolide	was	a	gift	from	María	García	(Merck	Research	
Laboratories,	New	 Jersey).	 The	 TRPA1	blocker	HC030031	was	 purchased	 from	Tocris	
Bioscience.	 DMSO	 was	 also	 used	 as	 vehicle	 for	 PS,	 nifedipine,	 BIBN,	 CIM0216	 and	
HC030031.	AngII	was	dissolved	in	saline	solution	(0.9%	NaCl)	and	Milli-Q®	purified	water	
was	used	as	vehicle	for	guanethidine,	phenylephrine,	UTP	and	potassium	blockers.	
3.11	Statistical	analysis	
In	all	experiments,	data	were	pooled	from	multiple	trials	carried	out	on	cells	or	arteries	
isolated	from	at	least	three	different	animals	and	summarized	as	means	±	SEM	and	dots	
plots	for	each	individual	measurement.	The	Origin	software	(version	9,	OriginLab)	was	
used	for	statistical	analysis	and	data	display.	Differences	between	means	were	assessed	
using	t-test	paired	or	unpaired	and	one-way	ANOVA,	Dunn-Sidak	test	comparisons.	*	P	
<	0.05;	#	P	<	0.01	were	taken	as	statistically	significant	difference	between	means	and	n	
denotes	the	sample	size.	
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The	results	in	this	chapter	were	integrally	published	in	Journal	of	Molecular	and	Cellular	Cardiology.	
Lucía	 Alonso-Carbajo	 performed	 the	 majority	 of	 the	 experiments	 and	 analyzed	 the	 data.	 The	
manuscript	was	written	by	her	with	input	from	the	other	authors.	
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Recent	 findings	 unveiling	 TRPM3	 as	 potential	 chemo-sensor	 in	 nociceptive	 neurons	 [62]	
suggest	that,	if	present	in	perivascular	nerve	endings,	activation	of	this	channel	might	result	
in	neuropeptide	 release.	This	would	suppose	a	vasodilating	effect	of	TRPM3	activation,	an	
action	opposite	to	the	vasoconstriction	previously	described	in	mouse	aorta [128].	In	order	to	
address	this	question,	we	investigated	the	localization,	function	and	mechanism	underlying	of	
TRPM3	in	mouse	mesenteric	arteries.		
4.1	Expression	pattern	of	TRPM	family	in	mouse	mesenteric	arteries	
We	first	determined	the	expression	of	the	genes	encoding	TRPM	channels	in	c57bl/6j	mouse	
mesenteric	arteries	with	and	without	endothelium.	Trpm1,	Trpm5	and	Trpm8	could	not	be	
detected	after	40	cycles	of	amplification	in	any	preparation.	In	contrast,	the	other	5	members	
of	 the	subfamily	were	detected	 in	preparations	with	endothelium	(Figure	4.1A).	We	found	
lower	 relative	 expression	 for	 Trpm4	 and	 Trpm7	 and	 no	 detectable	 Trpm2	 and	 Trpm6	 in	
preparations	 devoid	 of	 endothelium	 (Figure	 4.1A	 and	 B),	 suggesting	 for	 a	 preferential	
expression	of	these	transcripts	in	the	endothelial	layer.		
 
Figure	 4.1.	 Expression	 of	 TRPM	 family	 in	 mesenteric	 arteries	 with	 and	 without	 endothelium.	 (A)	
Relative	expression	of	Trpm	genes	 in	mesenteric	arteries	dissected	from	c57bl/6j	mice.	 (B)	Relative	
expression	 of	 Trpm	 genes	 in	 endothelium-denuded	 arteries	 using	 arteries	 with	 endothelium	 as	
calibrator.	Data	are	represented	as	mean	±	SEM,	*P < 0.05;	#P < 0.01	(n = 3),	one	way	ANOVA,	Dunn-
Sidak	test.	
	
In	 sharp	 contrast,	 we	 found	 higher	 relative	 levels	 of	 Trpm3	 mRNA	 in	 endothelium-free	
preparations,	indicating	for	a	predominant	expression	in	the	medial	and/or	adventitial	layers.	
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Of	 note,	 we	 found	 a	 much	 higher	 relative	 abundance	 of	 Trpm3	 mRNA	 in	 aorta	 than	 in	
mesenteric	arteries	(3.3	±	0.8;	n	=	3	versus	0.09	±	0.01;	n	=	3;	P	<	0.001).	
4.2	Localization	of	TRPM3	in	perivascular	nerves	of	mesenteric	arteries	
Confocal	images	of	mesenteric	arteries	labeled	with	the	neuronal	marker	PGP9.5	(Figure	4.2A)	
evidenced	the	presence	of	nerve	fibres	in	the	adventitial	layer.		
 
Figure	4.2.	TRPM3	is	located	in	perivascular	nerve	endings	of	mouse	mesenteric	arteries.	(A)	Z-stack	
confocal	 images	 of	 intact	 c57bl/6j	mouse	mesenteric	 arteries	 labelled	 with	 PGP9.5	 (red,	 left)	 and	
TRPM3	(green,	center)	antibodies.	An	overlay	of	these	 images	merged	with	a	nuclear	staining	DAPI	
(blue)	is	shown	on	the	right.	The	initial	position	was	set	where	no	nuclei	are	visible	and	the	steps	have	
1.03	μm	as	suggested	by	the	software.	The	image	shows	a	35.11	μm	thickness,	acquired	at	4.12	μm	
from	the	initial	position,	40X.	The	images	are	the	sum	of	16	readings	average	(B)	Confocal	microscopy	
images	of	the	adventitia	and	medial	layers	labelled	with	a	TRPM3	antibody	(green)	and	nuclear	DAPI	
staining	(blue).	The	white	arrowheads	in	the	bottom-right	image	point	to	TRPM3	labelling	observed	
only	in	the	adventitial	layer.	The	images	were	taken	by	repositioning	according	to	nuclei	morphology.	
Images	are	representative	of	at	least	3	independent	experiments.	
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We	found	that	TRPM3	colocalized	with	PGP9.5	(Figure	4.2A)	and	was	absent	in	cells	of	the	
tunica	media	(VSMC),	which	were	clearly	identified	by	the	distinct	orientation	of	their	nuclei,	
perpendicular	to	the	axis	of	the	vessel	(Figure	4.2B).	
The	localization	of	TRPM3	was	determined	with	an	antibody	whose	specificity	against	TRPM3	
was	confirmed	in	a	HEK293T	cell	 line	stably	transfected	with	this	channel	(Figure	4.3).	As	a	
control	 for	 the	experiment,	we	used	TRPM5-transfected	HEK293T	cells,	which	also	express	
TRPM7	 endogenously.	 We	 found	 that	 these	 cells	 were	 not	 stained	 with	 the	 anti-TRPM3	
antibody,	confirming	the	specificity	 for	TRPM3	versus	these	closely-related	TRPM	channels	
(Figure	4.3).		
	
Figure	 4.3.	 Specificity	 of	 a	 rabbit	 anti-TRPM3	 antibody.	 Confocal	 images	 of	 non-transfected	 cells	
incubated	 with	 the	 anti-TRPM3	 antibody,	 non-transfected	 cells	 incubated	 with	 the	 secondary	
antibody,	TRPM3-transfected	cells	labeled	with	the	anti-TRPM3	antibody	and	TRPM5-transfected	cells	
incubated	with	anti-TRPM3.	In	all	images	DAPI	staining	is	shown	in	blue	(objective	20X).	Images	are	
representative	of	at	least	3	independent	experiments.	
Of	note,	arteries	from	Trpm3	KO	mice	could	not	be	used	as	a	negative	control	for	the	TRPM3	
antibody,	because	these	animals	express	a	truncated	TRPM3	protein	that	can	be	recognized	
by	the	anti-TRPM3	antibody.	However,	we	took	advantage	of	the	fact	that	these	mice	have	
incorporated	a	β-galactosidase	(β-gal)	reporter	encoded	by	the	insertion	of	a	Lac-Z	gene	into	
the	reading	frame	of	the	Trpm3	gene [142].	Using	an	anti-β-gal	antibody	in	Trpm3	KO	mice,	
we	found	that	β-gal	colocalized	with	the	neuronal	markers	PGP9.5	(Figure	4.4A)	and	NF-200	
(Figure	4.5A)	and	was	absent	in	VSMC	(Figure	4.5B).	As	expected	for	negative	control,	c57bl/6j	
arteries	were	not	stained	with	the	anti-β-gal	antibody	(Figure	4.4B).		
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Figure	4.4.	Location	of	the	transgene	product	of	the	Trpm3	KO	mice	in	perivascular	nerve	endings	of	
mesenteric	arteries.	(A)	Z-stack	(31.89	μm	thickness)	confocal	images	of	intact	Trpm3	KO	mesenteric	
arteries	 at	 the	 levels	 of	 the	 adventitial	 (a),	 medial	 (b)	 and	 endothelial	 (c)	 layers,	 labeled	 with	 β-
galactosidase	 (green),	 PGP9.5	 (red)	 antibodies	 and	 nuclear	 DAPI	 (blue)	 staining.	 The	 total	 images	
acquired	were	50	(z	=	5,	b	=	15,	c	=	28)	with	steps	of	0.64	μm.	The	initial	and	final	positions	were	set	
where	no	nuclei	are	visible.	The	images	are	representative	of	at	least	3	independent	experiments.	(B)	
Confocal	microscopy	images	of	the	adventitial	layer	of	a	c57bl/6j	mouse	mesenteric	artery	labeled	with	
β-galactosidase	(green),	PGP9.5	(red)	antibodies	and	nuclear	DAPI	staining	(blue).	The	position	of	the	
image	was	set	according	to	nuclei	morphology.	Images	are	representative	of	3	independent.	
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Figure	4.5.		Perivascular	innervation	in	dissected	mouse	mesenteric	arteries.	Confocal	images	of	the	
adventitia	 (A)	 and	 the	 medial	 layer	 (B)	 of	 intact	 Trpm3	 KO	 mesenteric	 arteries	 labeled	 with	 b	
galactosidase	(green),	anti-NF-200	(red)	antibodies	and	nuclear	DAPI	(blue)	staining.	In	both	images,	
the	position	was	set	according	to	nuclei	morphology,	40X.	 Images	are	 representative	of	at	 least	3	
independent	experiments.	
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To	 further	 characterize	 the	 localization	 pattern	 of	 TRPM3	 we	 performed	 double	
immunostaining	 in	 intact	mesenteric	arteries	 from	Trpm3	KO	mice	 labeled	with	antibodies	
against	β-gal	and	the	smooth	muscle-specific	protein	alpha-smooth	muscle	actin	(α-SMA).	We	
found	α-SMA	to	be	present	as	expected	in	the	smooth	muscle	(Figure	4.6A),	but	not	in	the	
adventitial	layer	(Figure	4.6B).	In	contrast,	β-gal	was	clearly	detected	only	in	nerve	ending-like	
structures	in	the	adventitial	layer.	
 
Figure	4.6.	The	transgene	product	of	the	Trpm3	KO	mice	is	not	located	in	smooth	muscle	layer	from	
mesenteric	arteries.	Confocal	microscopy	 images	of	 the	medial	 layer	 (A)	and	adventital	 layer	 (B)	of	
Trpm3	KO	mouse	 intact	mesenteric	arteries	 labeled	with	β-galactosidase	 (green),	α-smooth	muscle	
actin	(red)	antibodies	and	nuclear	DAPI	staining	(blue).	In	both	images,	the	position	was	set	according	
to	nuclei	morphology,	40X.	Images	are	representative	of	at	least	3	independent	experiments.	
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To	 test	 directly	 whether	 TRPM3	 is	 functionally	 expressed	 in	 the	 medial	 layer	 of	 mouse	
mesenteric	arteries	we	performed	whole-cell	patch-clamp	recordings	 in	 freshly	dissociated	
VSMC.	 Application	 of	 PS	 (10	 and	 30	 μM)	 produced	 no	 significant	 change	 in	 the	 current	
amplitude	at	 -150	mV	and	+80	mV	 (99.9	±	0.5%	and	100	±	0.3%	relative	 to	 the	amplitude	
recorded	in	control	condition,	respectively;	n	=	12	cells	from	4	mice;	Figure	4.7A).		
 
Figure	4.7.	TRPM3	is	not	 functionally	expressed	 in	c57bl/6j	mouse	mesenteric	VSMC.	(A)	Left,	 time	
course	of	the	amplitude	of	currents	recorded	at	-80	and	+80	mV	in	control	and	in	the	presence	of	10	
and	30	μM	PS.	Right,	traces	recorded	in	control	(black)	and	in	the	presence	of	30	μM	PS	(grey).	(B,	C)	
Left,	representative	examples	of	the	time	course	of	the	amplitude	of	currents	recorded	at	-150	and	
+80	mV,	 showing	 the	 effects	 of	 100	μM	UTP,	 10	 μM	PS	 and	 2	 μM	CIM0216.	 Right,	 the	 I-V	 curves	
represent	the	differences	between	traces	recorded	in	the	presence	of	the	experimental	compounds	
(PS,	CIM	and	UTP)	at	the	time	points	indicated	by	the	labels	a	and	b	and	the	corresponding	current	
trace	recorded	in	control.	
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In	another	series	of	experiments,	the	effects	of	PS	(10	μM)	and	of	the	potent	TRPM3	synthetic	
agonist	CIM0216	[135]	on	current	amplitude	were	compared	to	the	effects	of	the	purinergic	
receptor	 agonist	 UTP [204].	 Again,	 there	 was	 no	 change	 in	 current	 amplitude	 during	 PS	
application	(-0.3	±	0.3	pA,	P	=	0.95,	at	-150	mV	and	1.3	±	0.9	pA,	P	=	0.77	at	+80	mV	(n	=	6	cells	
from	3	mice;	Figure	4.7B,	black	trace	in	right	panel).	Currents	were	also	unaffected	by	2	μM	
CIM0216	(current	amplitude	change	of	-0.5	±	1.7	pA,	P	=	0.99	at	-150	mV	and	2	±	2	pA,	P	=	
0.77	at	+80	mV;	n	=	4	cells	from	2	mice;	Figure	4.7C,	black	trace	in	right	panel).	On	the	other	
hand,	 currents	 were	 stimulated	 at	 negative	 potentials	 by	 100	 μM	 UTP,	 as	 expected.	 The	
amplitude	of	the	UTP-sensitive	current	was	-51	±	9	pA,	P	=	0.003	at	-150	mV	and	2.7	±	0.7	pA,	
P	=	0.26	at	+80	mV;	n	=	5	cells	from	2	mice	(Figure	4.7B	and	C,	grey	traces	in	right	panels).	
Taken	together,	these	data	indicate	the	absence	of	functional	expression	of	TRPM3	channels	
in	mesenteric	arteries	VSMC.	
4.3	 TRPM3	 activation	 induces	 vasodilation	 mainly	 via	 stimulation	 of	 CGRP	
receptors	
To	determine	the	effects	of	TRPM3	activation	in	resistance	arteries	we	performed	pressure	
myography	 experiments	 in	 endothelium-denuded	 mouse	 mesenteric	 arteries.	 Pressurized	
arteries	were	pre-contracted	with	10	μM	phenylephrine	to	maintain	the	physiological	tone	
and	at	the	end	of	each	experiment,	we	applied	the	L-type	Ca2+	channel	blocker	nifepidine	(10	
μM)	to	determine	the	maximum	arterial	diameter.	Nifedipine	was	previously	reported	as a	
TRPM3	agonist	[130].	Thus,	 it	could	be	argued	that	nifedipine-induced	vasodilation	may	be	
partly	mediated	by	TRPM3,	making	this	compound	unsuitable	for	the	determination	of	the	
role	of	this	channel.	To	test	this,	we	compared	the	vasodilation	elicited	in	the	same	artery	by	
10	 μM	nifedipine	 application	 and	 by	 perfusion	with	 Ca2+-free	 bath	 solution.	We	 observed	
similar	increase	in	the	arterial	diameter	in	both	cases	(Figure	4.8).	This	demonstrates	that	10	
μM	of	nifedipine	has	the	same	effect	than	abrogating	Ca2+	entry	through	L-type	Ca2+	channels,	
thus	validating	its	use	to	determine	the	maximal	vasodilation.	
PS	 induced	 a	 dose-dependent	 reversible	 vasodilation	 in	 arteries	 dissected	 from	 c57bl/6j	
animals.	The	data	was	best	fit	by	the	sum	of	two	Hill	functions,	suggesting	for	at	 least	two	
targets	of	PS	(Figure	4.9A	and	D).	The	EC50	values	for	these	components	were	14	±	2	μM	and	
100	 ±	 9	 μM	 and	 the	 corresponding	 Hill	 coefficients	 (H)	 were	 2.2	 ±	 0.5	 and	 4.3	 ±	 1.2,	
respectively.	This	fitting	also	yielded	a	value	of	relative	amplitude	of	the	low	EC50	vasodilation	
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component	of	57	±	7%	(A1,	see	the	two-Hill	components	equation	in	the	Methods,	section	
Pressure	myography	experiments).	To	determine	the	contribution	of	TRPM3	channels	to	the	
effects	of	PS	we	measured	the	response	of	mesenteric	arteries	isolated	from	Trpm3	KO	mice.	
PS	dilated	Trpm3	KO	arteries	only	at	concentrations	higher	than	~10	μM	(Figure	4.9B	and	D).		
	
 
Figure	4.8.	Nifedipine	(10	µM)	induces	maximal	vasodilation	in	mouse	mesenteric	arteries.	Comparison	
of	 the	 vasodilating	 effects	 of	 a	 Ca2+-free	 solution	 and	 10	 µM	 nifedipine	 (Nif)	 in	 c57bl/6j	
arteries.	Phenylephrine	is	defined	as	Phe.	
	
The	dose-response	curve	for	Trpm3	KO	arteries	could	be	fitted	with	a	single	Hill	function,	with	
EC50	and	Hill	values	of	53	±	3	μM	and	2.2	±	0.2,	respectively.	These	results	further	support	the	
idea	 that	 in	 c57bl/6j	 arteries	 there	 are	 two	 different	mechanisms	 involved	 in	 PS-induced	
vasodilation,	being	only	the	one	with	lower	EC50	TRPM3-dependent.		
In	 addition,	 CIM0216	 induced	 a	 dose-dependent	 reversible	 vasodilation	 in	 arteries	 from	
c57bl/6j	animals,	with	EC50	and	Hill	 coefficients	values	of	0.40	±	0.05	μM	and	0.65	±	0.06,	
respectively	(Figure	4.10A	and	C).	Arteries	dissected	from	Trpm3	KO	mice	responded	to	this	
compound,	but	at	concentrations	higher	than	0.1	μM,	with	EC50	and	Hill	coefficient	values	of	
1.50	±	0.08	μM	and	1.6	±	0.1,	respectively	(Figure	4.10B	and	C).	
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Figure	 4.9.	 TRPM3-induced	 vasodilation	 of	 mesenteric	 arteries	 is	 mediated	 by	 CGRP	 receptor	
activation.	 Representative	 examples	 of	 the	 effects	 of	 increasing	 concentrations	 of	 pregnenolone	
sulfate	(PS,	in	μM)	on	the	diameter	of	arteries	dissected	from	c57bl/6j	(A)	and	Trpm3	KO	mice	(B)	in	
the	 presence	 of	 phenylephrine	 (Phe,	 10	 μM).	 (C)	 Effects	 of	 PS	 (in	 μM)	 on	 c57bl/6j	 arteries	 in	 the	
presence	of	the	CGRP	receptor	antagonist	BIBN	4096	(1	μM)	and	phenylephrine	(10	μM).	Nifedipine	
(Nif,	 10	 μM)	 was	 applied	 at	 the	 end	 of	 each	 experiment.	 (D)	 Dose	 dependency	 of	 PS-induced	
vasodilation	(in	μM)	in	precontracted	arteries	dissected	from	c57bl/6j,	Trpm3	KO	mice	and	in	c57bl/6j	
arteries	in	the	presence	of	1	μM	BIBN	4096.	Data	are	mean	±	SEM	(c57/bl6j,	n	=	10;	Trpm3	KO,	n	=	8	
and	c57bl/6j	+	BIBN	4096,	n	=	8).	The	black	solid	line	represents	the	fit	of	the	c57bl/6j	data	with	a	two-
component	Hill	equation.	The	grey	solid	line	and	the	dotted	line	represent	the	fit	of	the	data	for	Trpm3	
KO	and	c57bl/6j	in	the	presence	of	BIBN	4096	with	single-component	Hill	equations.	*	indicates	P	<	
0.05	 compared	 to	 c57bl/6j	 mice,	 unpaired	 t-test.	 (E)	 Confocal	 images	 of	 intact	 Trpm3	 KO	mouse	
mesenteric	arteries	of	the	adventitial	layer	labeled	with	β-	galactosidase	(green),	CGRP	(red)	antibodies	
and	nuclear	DAPI	staining	(blue).	The	position	was	set	according	to	the	nuclei	morphology,	40X.	Images	
are	representative	of	at	least	3	independent	experiments.	
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Figure	 4.10.	 A	 synthetic	 potent	 agonist	 of	 TRPM3	 induces	 vasodilation	 of	 endothelium-denuded	
mesenteric	arteries.	Representative	examples	of	the	effects	of	CIM0216	at	different	concentrations	
applied	 on	 the	 diameter	 of	 arteries	 dissected	 from	 c57bl/6j	 (A)	 and	Trpm3	 KO	mice	 (B).	 (C).	 Dose	
dependency	of	CIM0216-induced	vasodilation	in	arteries	dissected	from	c57bl/6j	and	Trpm3	KO	mice.	
Nifedipine	(Nif,	10	μM)	was	applied	at	the	end	of	each	experiment.	Data	are	mean	±	SEM	(c57/bl6j,	n	
=	4	and	Trpm3	KO,	n	=	4).	The	black	and	grey	solid	lines	represent	the	fit	of	the	c57bl/6j	and	Trpm3	KO	
data,	respectively,	with	a	single-component	Hill	equation.	Phe	=	Phenylephrine.	*	indicates	P	<	0.05	
compared	to	c57bl/6j	mice,	paired	t-test.	
	
Based	on	prior	studies	on	sensory	TRP	channels	such	as	TRPV1	and	TRPA1 [102,	205] and	the	
expression	 of	 TRPM3	 in	 nociceptive	 neurons	 [62,	 135],	 as	 well	 as	 the	 well-stablished	
neuroanatomical	localization	of	CGRP	in	perivascular	nerves	innervating	the	adventitial	layer 
[206-209],	we	hypothesized	that	the	TRPM3-dependent	vasodilation	induced	by	PS	may	be	
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mediated	by	the	release	of	CGRP	and	the	relaxing	effect	of	this	peptide	on	VSMC.	To	test	this,	
we	performed	myography	experiments	in	the	presence	of	the	CGRP	receptor	antagonist,	BIBN	
4096.	In	this	condition,	PS-induced	vasodilation	could	only	be	elicited	at	concentrations	above	
10-15	μM	(Figure	4.9C).	The	dose-response	curve	of	the	effect	of	PS	in	the	presence	of	BIBN	
4096	(1	μM)	was	similar	to	the	curve	obtained	in	arteries	from	Trpm3	KO	mice,	with	EC50	and	
H	 values	 of	 44	 ±	 2	 μM	 and	 1.8	 ±	 0.1,	 respectively	 (Figure	 4.9D).	 Furthermore,	 double	
immunolabelling	of	intact	mesenteric	arteries	from	Trpm3	KO	mice	with	anti-β-gal	and	anti-
CGRP	 antibodies	 showed	 a	 good	 colocalization	 in	 the	 sensory	 fibres	 that	 innervate	 the	
adventitial	 layer	 (Figure	 4.9E).	 These	 results	 indicate	 that	 TRPM3	 location	 seems	 to	 be	
restricted	 to	 sensory	 nerve	 endings,	where	 the	 TRPM3-mediated	 effect	 of	 PS	 depends	 on	
CGRP	receptor	activation.		
The	vasodilating	action	of	CGRP	has	endothelium-dependent	and	endothelium	independent	
components,	which	are	mediated	by	the	stimulation	of	CGRP	receptors	 in	endothelial	cells	
and	VSMC,	respectively	[19,	22].	Thus,	the	TRPM3-dependent	effect	of	PS	is	expected	to	be	
stronger	 in	 the	 presence	 of	 endothelium.	We	 found	 that	 this	was	 indeed	 the	 case,	 as	 PS	
induced	a	dose-dependent	biphasic	effect	in	intact	arteries	(Figure	4.11A),	with	EC50	values	
lower	than	the	corresponding	ones	found	in	endothelium	denuded	preparations	(8.1	±	0.5	μM	
and	50	±	2	μM)	(Figure	4.11B).	
4.4	CGRP	release	induces	vasodilation	via	activation	of	K+	channels	
Next,	 we	 explored	 the	mechanisms	 by	 which	 CGRP	 receptor	 activation	 in	 VSMC	 leads	 to	
vasodilation.	Stimulation	of	the	CGRP	receptor	has	been	reported	to	increase	cyclic	adenosine	
monophosphate	 (cAMP)	production	via	 the	adenylate	cyclase	 (AC) [20]	and	may	 therefore	
lead	to	protein	kinase	A	(PKA)-mediated	activation	of	K+	channels	in	VSMC	hyperpolarization	
and	arterial	relaxation.		
To	test	whether	activation	of	K+	channels	is	involved	in	the	vasodilation	response	triggered	by	
TRPM3	activation	we	compared	 the	effects	of	10	μM	PS	 in	arteries	 treated	or	not	with	K+	
channel	blockers.	We	noticed	that	the	vasodilation	induced	by	acute	application	of	10	μM	PS	
(42	 ±	 4	%)	 in	 the	 presence	 of	 phenylephrine	 (10	 μM)	 (Figure	 4.13A)	was	 larger	 than	 that	
induced	by	the	same	concentration	during	the	cumulative	dose-response	experiments	(18	±	
4%).	This	may	be	due	to	partial	CGRP	depletion	induced	by	previous	applications	of	PS	at	low	
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concentrations.	Nevertheless,	the	effects	of	cumulative	(Figure	4.9D)	or	acute	(Figure	4.12)	
application	of	10	μM	PS	were	largely	mediated	by	CGRP.	
 
Figure	 4.11.	 TRPM3-induced	 vasodilation	 of	 mesenteric	 arteries	 is	 enhanced	 by	 endothelium.	 (A)	
Representative	example	of	the	vasodilation	induced	by	PS	in	a	c57bl/6j	mouse	mesenteric	artery	with	
endothelium	precontrated	with	phenylephrine	(10	µM).	At	the	end	of	each	experiment,	Nif	(10	μM)	
was	applied.	(B)	Comparison	of	the	dose	responses	to	PS	in	precontrated	arteries	with	endothelium	(n	
=	8)	and	without	endothelium	(n	=	10,	same	data	as	in	Figure	5.8D	is	shown	for	comparison).	The	solid	
lines	 represent	 the	 best	 fit	 of	 the	 data	 with	 two-component	 Hill	 equations.	 *	 indicates	 P	 <	 0.05	
compared	to	the	corresponding	data	for	c57bl/6j	without	endothelium,	unpaired	t-test. 
								
	
	
	
	
Figure	 4.12.	 PS-induced	 vasodilation	 is	
markedly	 reduced	 in	 the	 presence	 of	 the	
CGRP	antagonist.	Effects	of	PS	(10	µM	and	25	
µM)	on	a	c57bl/6j	mouse	mesenteric	artery	
in	 the	 presence	 of	 the	 CGRP	 receptor	
antagonist	BIBN	4096.	Phe	=	Phenylephrine,	
PS	 =	 pregnenolone	 sulfate	 and	 Nif	 =	
nifedipine.	
Pretreatment	with	the	voltage-	and	Ca2+-activated	K+	channel	blocker	paxilline	(500	nM)	[210]	
and	the	KV1	channels	blocker	correolide	 (10	μM)	 [211]	 led	to	a	significant	reduction	of	 the	
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effect	of	PS	on	pre-contracted	mesenteric	arteries.	This	effect	was	enhanced	by	addition	of	
the	KV2	blocker	stromatoxin	(ScTx1,	50	nM)	(Figure	4.13A	and	B) [212].		
 
Figure	 4.13.	 TRPM3-dependent	 vasodilation	 is	 partly	 mediated	 by	 activation	 of	 K+	 channels.	 (A)	
Comparison	 of	 the	 effects	 of	 pregnenolone	 sulfate	 (PS,	 10	 μM)	 in	 control	 conditions	 and	 in	 the	
presence	of	the	K+	channel	blockers	paxilline	(500	nM),	correolide	(10	μM)	and	stromatoxin	(50	nM).	
The	scheme	shows	the	CGRP	signaling	cascade	leading	to	activation	of	K+	channels	via	stimulation	of	
adenylate	cyclase	(AC)	and	protein	kinase	A	(PKA)	in	VSMC.	(B)	Average	vasodilator	effects	of	10	μM	
PS	 on	 c57bl/6j	mesenteric	 arteries	 in	 control	 conditions	 (n	 =	 14),	 in	 the	 presence	 of	 paxilline	 and	
correolide	(n	=	8)	and	in	the	presence	of	paxilline,	correolide	and	stromatoxin	(n	=	5).	**	indicate	P	<	
0.05	for	the	comparison	with	the	data	obtained	in	control,	unpaired	t-test.	Phe	=	Phenylephrine;	Nif	=	
nifedipine.	
None	of	these	compounds	affected	the	responses	of	HEK293T	cells	stably	transfected	with	
mouse	TRPM3	to	PS	(Figure	4.14A),	indicating	that	they	did	not	target	TRPM3	in	the	arterial	
preparations.	We	also	probed	for	direct	modulatory	effects	of	PS	on	KV	channels	in	whole-cell	
patch-clamp	experiments	performed	in	mesenteric	VSMC	freshly	isolated	from	c57bl/6j	and	
Trpm3	KO	mice.	Current-voltage	relationships	elicited	in	c57bl/6j	and	in	Trpm3	KO	VSMC	by	
depolarizing	pulses	were	unaffected	by	application	of	PS	(10	and	30	μM;	Figure	4.14B	and	C).	
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Figure	4.14.	Absence	of	non-specific	effects	of	K+	channel	blockers	on	TRPM3	channels	or	PS	on	K+	
channels.	(A)	Intracellular	Ca2+	signals	in	HEK293T-TRPM3	cells	stimulated	with	10	μM	PS	in	control	(n	
=	 25)	 was	 not	 affected	 by	 the	 presence	 of	 a	 cocktail	 of	 K+	 channel	 blockers	 including	 paxilline,	
correolide	and	stromatoxin	 (n	=	25).	Voltage-dependence	of	 the	amplitude	of	K+	currents	 recorded	
VSMC	isolated	from	c57bl/6j	(n	=	10)	(B)	and	Trpm3	KO	(n	=	10)	(C)	mice	in	control	and	in	the	presence	
of	10	or	30	μM	PS.	
We	 further	 assessed	 the	 implication	of	 the	 cAMP	pathway	and	K+	 channels	by	 testing	 the	
effects	 of	 forskolin,	 a	 direct	 activator	 of	 AC,	 both	 in	 the	 absence	 and	 in	 the	 presence	 of	
paxilline,	correolide	and	stromatoxin.	We	found	1	μM	forskolin	induce	strong	vasodilation,	an	
effect	 that	was	 significantly	 attenuated	 in	 the	presence	of	 the	K+	 channel	blockers	 (Figure	
4.15A	and	B).	 Taken	 together,	 these	 results	 indicate	 that	 the	 TRPM3-mediated	dilation	 of	
mesenteric	arteries	is	at	least	partly	mediated	by	the	activation	of	KV	channels	in	VSMC.	
4.5	Sympathetic	nerves	are	not	implicated	in	TRPM3-mediated	vasodilation	
The	tone	of	mesenteric	arteries	is	regulated	by	sympathetic	innervation	through	the	release	
of	 noradrenaline.	 The	 dominant	 effect	 of	 noradrenaline	 on	 mesenteric	 arteries	 is	 α1-
adrenoreceptor-mediated	 vasoconstriction,	 but	 mesenteric	 VSMC	 also	 express	 β2-	
adrenoreceptors,	whose	activation	could	 induce	vasodilation.	 If	TRPM3	channels	were	also	
expressed	in	sympathetic	nerve	endings,	PS-induced	dilation	of	mesenteric	arteries	could	be	
partly	 mediated	 by	 the	 activation	 of	 β2-adrenoreceptors.	We	 used	 several	 approaches	 to	
assess	this	possibility.	First,	we	studied	the	functional	contribution	of	β2-adrenoreceptors	to	
the	sympathetic	response.	The	application	of	20	μM	noradrenaline	led	to	a	vasoconstriction	
that	was	not	affected	by	the	application	of	the	selective	β2-	antagonist	propranolol	(1	μM	and	
5	μM,	Figure	4.16A).	This	suggests	that	the	effects	of	sympathetic	stimulation	on	mesenteric	
vessels	are	exclusively	mediated	by	noradrenaline	acting	on	α1-adrenoreceptors.	Consistently	
with	this,	we	failed	to	find	any	vasodilation	in	response	to	noradrenaline	application	in	Phe-
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pre-contracted	arteries	(Figure	4.16B).	In	another	series	of	experiments,	we	found	that	PS	(10	
μM)	induced	vasodilation	in	the	presence	of	5	μM	propranolol	(Figure	4.16C,	40.3	±	1.2	μM,	n	
=	3),	further	indicating	that	β2-adrenoreceptors	are	not	involved	in	the	vasodilation	induced	
by	PS.		
	
	
Figure	4.15.	Stimulation	of	adenylate	cyclase	induces	a	strong	vasodilation	attenuated	in	the	presence	
of	 K+	 channels.	 (A)	 Representative	 example	 of	 the	 effect	 of	 1	 μM	 forskolin	 on	 a	 c57bl/6j	 mouse	
mesentery	 artery	 in	 control	 and	 in	 the	 presence	 of	 the	 K+	 channel	 blockers	 paxilline	 (500	 nM),	
correolide	(10	μM)	and	stromatoxin	(50	nM).	(B)	Average	vasodilator	effect	of	1	μM	forskolin	in	the	
absence	(n	=	4)	and	in	the	presence	of	K+	channel	blockers	(n	=	4).	Phe	=	Phenylephrine;	Nif	=	nifedipine.	
**	indicates	P	<	0.05	versus	control,	paired	t-test.	
	
In	addition,	we	performed	double	immunostainings	of	intact	mesenteric	arteries	of	Trpm3	KO	
mice	using	anti-β-gal	and	anti-Tyrosine	hydroxylase	(TH)	antibodies.	We	found	β-gal	positive	
structures	 in	 the	 adventitia	 that	 were	 clearly	 not	 stained	 for	 TH	 (Figure	 4.17),	 white	
arrowheads	in	the	bottom-left	panel).	We	did	observe	some	overlap	between	β-gal-	and	TH-
positive	structures,	but	it	seems	that	this	was	due	to	their	close	proximity	and	not	to	an	actual	
co-expression	of	β-gal	and	TH	in	the	same	nerve	endings	(Figure	4.16,	adventitia,	left	panels).	
The	reason	for	this	is	that	the	β-gal	labeling,	but	not	the	TH	one,	was	progressively	lost,	as	the	
images	were	taken	closer	to	the	medial	layer	(Figure	4.17,	advent.	+	VSMC,	right	panels).	Note	
that	it	seems	highly	unlikely	that	β-gal	and	TH	would	localize	in	the	same	fibres	and	that	only	
the	expression	of	the	former,	being	an	exogenous	and	probably	unregulated	protein,	suddenly	
stops	 at	 the	 points	 of	 fibres	 entry	 into	 the	 medial	 layer.	 Altogether,	 our	 functional	 and	
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anatomical	 experiments	 point	 to	 a	 lack	 of	 involvement	 of	 sympathetic	 fibres	 in	 TRPM3-
mediated	vasodilation. 
 
Figure	 4.16. Sympathetic	 perivascular	 nerves	 are	 not	 involved	 in	 TRPM3-induced	 vasodilation	 of	
mesenteric	 arteries.	 (A)	Representative	 example	 of	 the	 effect	 of	 noradrenaline	 (NA,	 20	 μM)	 on	 a	
c57bl/6j	mesentery	artery	in	the	presence	of	the	β-adrenoreceptor	blocker	propranolol	(PRO,	1	μM	in	
the	 left	panel	and	5	μM	 in	 the	 right	panel).	 (B)	Effect	of	10	μM	noradrenaline	on	c57bl/6j	arteries	
precontracted	with	phenylephrine	(Phe,	20	μM).	(C)	Effect	of	PS	(10	μM)	in	the	presence	of	propranolol	
(5	μM).	Nifedipine	(10	μM)	was	applied	at	the	end	of	each	experiment.		
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Figure	 4.17. Confocal	 images	 of	 intact	 Trpm3	 KO	 mouse	 mesenteric	 arteries	 at	 the	 level	 of	 the	
adventitial	(left	panels)	and	closer	to	the	medial	(right	panels)	layers,	labeled	with	nuclear	DAPI	staining	
(blue),	β-galactosidase	(green)	and	Tyrosine	hydroxylase	(red).	Images	are	representative	of	at	least	3		
independent	experiments.	The	position	was	set	according	to	nuclei	morphology,	40X.
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5.1	 TRPA1	 and	 TRPM8	 channels	 are	 involved	 in	 intrinsic	 vascular	
responses	to	cold	
It	 is	 well	 known	 that	 cold	 induces	 vasoconstriction	 in	 skin	 blood	 vessels	 as	 a	 protective	
response	 against	 heat	 loss.	 This	 phenomenon	 is	 thought	 to	 be	 mediated	 by	 an	 efferent	
physiological	reflex	in	response	to	the	activation	of	cold-sensitive	afferent	nerves	[213].	The	
mechanism	underlying	this	process	has	been	described	to	be	mediated	by	activation	of	TRPA1	
and	 TRPM8	 channels	 in	 sensory	 neurons.	 On	 the	 other	 hand,	 the	 control	 of	 regional	
circulations	and	the	local	vasomotor	responses	to	thermal	stimulus	has	also	been	proposed	
by	Bowell [214]	;	however,	the	mechanisms	underlying	and	the	molecular	players	involved	in	
these	responses	are	still	unclear.	
In	order	to	determine	whether	TRPA1	and	TRPM8	channels	are	involved	in	the	intrinsic	cold-
induced	 vascular	 response,	 we	 performed	 pressure	 myography	 experiments	 in	 isolated	
plantar	 arteries	 from	 male	 mice.	 Following	 baseline	 measurements	 under	 physiological	
solution	with	1	µM	Phe	at	37	oC,	the	arteries	were	exposed	to	cold	solution	(10	oC	for	at	least	
5	min)	and	finally	to	the	L-type	Ca2+	channel	blocker	nifepidine	(10	μM)	in	order	to	determine	
the	maximum	arterial	diameter.		
We	found	that	cold	solution	(10	oC)	induced	a	contraction	in	endothelium-denuded	plantar	
arteries	 dissected	 from	 c57bl/6j	mice	 (29	 ±	 2.8	%,	 n	 =	 6;	 Figure	 5.1A	 and	 C).	 In	 previous	
experiments,	if	the	myogenic	tone	was	not	induced	to	the	arteries,	they	did	not	response	to	
cold	temperature.	Therefore,	all	the	arteries	were	precontrated	with	1	µM	Phe	before	starting	
the	experiment.		In	order	to	explore	if	the	cold-induced	effect	was	only	restricted	to	cutaneous	
vascular	beds,	we	exposed	internal	arteries	of	the	body	such	as	mesenteric	arteries	to	cold	
solution	and	we	observed	that	in	contrast	to	plantar	arteries,	the	vasoconstrictor	responses	
by	low	temperatures	were	not	observed	in	these	arteries	(1.6	±	1.02	%,	Figure	5.1B	and	C).	
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	C	
Figure	 5.1.	 Vascular	 response	 to	 cold	 in	 different	 types	 of	
vascular	 beds.	 (A)	 Representative	 example	 of	 a	 pre-
contracted	 plantar	 artery	 which	 is	 modulated	 by	 low	
temperatures	 (18	 oC).	 (B)	 Example	 of	 a	 pre-contracted	
mesenteric	artery	showing	the	lack	of	reaction	against	cold	
stimulation	(10	oC).	(C)	Mean	values	of	the	effect	in	response	
to	 cold	 in	 plantar	 arteries	 (n	 =	 6)	 and	mesenteric	 arteries	
from	c57bl/6j	(n	=	4;	*p	<	0.005,	one-way	ANOVA). 
	
	
	
In	plantar	arteries,	the	maximum	vasoconstriction	was	observed	at	1	to	4	min	following	local	
cooling	and	was	determined	as	the	percentage	decrease	in	diameter	from	the	baseline	before	
cold	and	the	maximum	diameter	of	the	artery	using	Eq.	3.4.	Exposure	of	plantar	arteries	from	
c57bl/6j	mice	to	10	oC	revealed	a	significantly	vasoconstriction	(28	±	3.01%,	n	=	9;	Figure	5.2A	
and	D)	that	was	significantly	less	in	plantar	arteries	dissected	from	Trpa1	KO	mice	(11.04	±	
2.78%,	n	=	11,	*p	<	0.005;	Figure	5.2B	and	D).		
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Figure	 5.2.	 TRPA1	 channel	 as	 a	 cold	 sensor	 in	 plantar	 artery.	 (A)	 In	 c57bl/6j	 plantar	 arteries,	 cold	
stimulation	induces	vasoconstriction.	(B)	Low	temperature	does	not	produce	any	effect	on	Trpa1	KO	
plantar	arteries.	(C)	Reduced	effect	of	cold	in	the	presence	of	the	TRPA1	blocker	HC030031	(10	μM).	
(D)	Mean	values	of	the	effect	in	response	to	cold	in	plantar	arteries	from	c57bl/6j	(n	=	9),	Trpa1	KO	(n	
=	11)	and	in	the	presence	of	HC030031	(n	=	6;	*p	<	0.005,	one-way	ANOVA).		
The	 responses	 of	 plantar	 arteries	 to	 cold	 were	 also	 significantly	 smaller	 in	 c57bl/6j	 mice	
pretreated	with	the	TRPA1	antagonist	HC030031	(9	±	2.23%,	n	=	6,	*p	<	0.005;	Figure	5.2C	and	
D),	while	removal	of	the	inhibitor	cold-induced	response	was	restored	to	control	(31	±	2.02%,	
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n	=	6).	Thus,	TRPA1	channels	partially	mediates	the	vasoconstrictor	response	of	the	local	cold-
induced	vascular	response.		
 
Figure	 5.3.	 Cold-induced	 vascular	 responses	 are	 not	 dependent	 on	 TRPV4	 or	 TRPM3.	 (A)	 Cold	
stimulation	induces	vasoconstriction	in	Trpv4	KO	(A)	and	Trpm3	KO	(B)	plantar	arteries.	(C)	Reduced	
effect	of	cold	in	Trpm3/Trpa1	KO	plantar	arteries.	(D)	Mean	values	of	the	effect	in	response	to	cold	in	
plantar	arteries	from	Trpv4	KO	(n	=	4),	Trpm3	KO	(n	=	4)	and	Trpm3/Trpa1	KO	(n	=	7;	*p	<	0.005).		
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On	 the	 other	 hand,	 gene	 deletion	 of	 Trpv4	 or	 Trpm3	 (two	 predicted	 warm	 temperature	
sensors	 from	 25	 to	 34	 oC	 [62,	 215])	 did	 not	 alter	 cold-induced	 vascular	 responses	 with	
contraction	amplitudes	similar	to	that	of	c57bl/6j	arteries	(27	±	2.9%,	n	=	4	for	Trpv4	KO,	24	±	
3.4%,	n	=	4	for	Trpm3	KO;	Figure	5.3A,	B	and	D).	Finally,	experiments	in	plantar	arteries	from	
Trpm3/Trpa1	KO	mice	yielded	similar	results	as	in	Trpa1	KO	mice	(8	±	1.2%,	n	=	7;	Figure	5.3C	
and	D)	confirming	the	essential	role	of	TRPA1	in	the	cold	response.	
 
Figure	 5.4.	 Role	 of	 TRPM8	 in	 the	 effects	 of	 cold.	 (A)	 Plantar	 artery	 from	 Trpm8	 mice	 shows	
vasoconstriction	 in	 response	 to	 cold.	 (B)	 Cold-induced	 vasoconstriction	 is	 reduced	 in	 Trpm8	 KO	
arteries.	 (C)	 The	 cold-induced	 effect	 is	 completely	 abolished	 in	 Trpm8	 KO	 plantar	 arteries	 in	 the	
presence	of	HC030031	(10	μM).	(D)	Mean	values	of	the	effect	in	response	to	cold	in	plantar	arteries	
from	Trpm8	+/+	(n	=	6),	Trpm8	KO	(n	=	6)	and	Trpm8	KO	in	the	presence	of	HC030031	(n	=	5;	*p	<	0.005,	
one-way	ANOVA).	
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TRPM8	 rather	 than	 TRPA1	 is	 considered	 to	 have	 an	 important	 role	 in	 cold	 sensation.	 The	
responses	of	Trpm8	KO	plantar	arteries	were	reduced	in	comparison	to	those	of	TRPM8	+/+	
arteries	(31	±	3.9%,	n	=	6	for	Trpm8	+/+	and	10	±	1.5%,	n	=	6	for	Trpm8	KO;	Figure	5.4A,	B	and	
D).	 In	 addition,	 application	 of	HC030031	 to	 plantar	 arteries	 from	Trpm8	KO	mice	 virtually	
abolished	 the	 responses	 to	 cold	 (2	 ±	 1.1%,	 n	 =	 5;	 Figure	 5.4C	 and	 D)	 indicating	 that	 the	
combined,	additive	activation	of	TRPA1	and	TRPM8	channels	accounts	 for	 the	whole	cold-
induced	vasoconstrictor	response. 
5.2	 Implication	of	 the	perivascular	 innervation	 in	 intrinsic	vascular	
responses	to	cold	
Next,	we	explored	the	mechanism(s)	through	which	TRPA1	and	TRPM8	mediate	cold-induced	
vascular	 response.	 Neither	 TRPA1	 nor	 TRPM8	 channels	 could	 be	 detected	 in	 VSMC	 from	
plantar	arteries,	suggesting	that	the	response	is	mediated	by	activation	of	these	channels	in	
perivascular	 sensory	 or	 sympathetic	 nerves	 via	 neuropeptides	 or	 catecholamine	 release,	
respectively.	If	these	cold-sensitive	channels	were	present	in	sensory	nerves,	their	activation	
may	 lead	 to	 vasodilation.	 We	 observed	 that	 in	 c57bl/6j	 plantar	 arteries	 cold-induced	
vasoconstriction	was	potentiated	in	the	presence	of	the	CGRP	receptor	inhibitor	BIBN	(40	±	
4.26	%,	n	=	8;	Figure	5.5A	and	D),	consistent	with	the	idea	of	a	subpopulation	of	these	channels	
being	expressed	in	sensory	terminals.	
On	the	other	hand,	if	the	TRPA1	or	TRPM8	channels	participating	in	this	response	were	also	
expressed	in	sympathetic	terminals,	their	activation	is	expected	to	produce	vasoconstriction.	
Indeed,	we	found	that	guanethidine-induced	depletion	(10	μM)	of	the	peripheral	sympathetic	
nerves	caused	a	significant	vasodilation	on	the	cold-induced	response	(9	±	2.6%,	n	=	7;	Figure	
5.5B	and	D).	No	effect	on	vessel	diameter	was	elicited	by	cold	when	arteries	were	incubated	
with	both	guanethidine	(10	μM)	and	BIBN	4096	(1	μM)	(2	±	1.1%,	n	=	5;	Figure	5.5C	and	D).	
These	data	indicate	that	cold	activates	TRPA1	and/or	TRPM8	channels	expressed	in	sensory	
and	sympathetic	neurons.	The	cold-induced	vascular	response	in	the	presence	of	BIBN	(1	μM)	
and/or	guanethidine	(10	μM)	in	Trpm8	+/+	mice	did	not	differ	from	the	one	found	in	c57bl/6j	
(Figure	5.6).		
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Figure	5.5.	Cold-induced	vascular	 response	 involves	sensory	and	sympathetic	nerves	activation.	 (A)	
Cold	 induces	 relaxation	 in	 the	 presence	 of	 NA	 release	 blocker	 guanethidine	 (10	 μM).	 (B)	 Cold-
dependent	vasoconstriction	 is	 increased	 in	the	presence	of	CGRP	antagonist	 (BIBN)	(1	μM).	 (C)	The	
mixture	of	both	blockers	almost	completely	abolished	the	cold	effect.	(D)	Mean	values	of	the	effect	in	
response	 to	 cold	 in	 plantar	 arteries	 from	 Trpm8	 +/+	 (n	 =	 6),	 in	 the	 presence	 of	 BIBN	 (n	 =	 5),	
guanethidine	(n	=	4)	and	both	blockers	(n	=	5).	
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Figure	5.6.	Cold-induced	vascular	response	also	involves	sensory	and	sympathetic	terminals	in	Trpm8	
+/+	mice.	(A)	Cold	induces	relaxation	in	the	presence	of	NA	release	blocker	guanethidine	(10	μM).	(B)	
Cold-dependent	vasoconstriction	is	increased	in	the	presence	of	CGRP	antagonist	(BIBN,	10	μM).	(C)	
The	mixture	of	both	blockers	inhibits	the	cold	effect.		(D)	Mean	values	of	the	effect	in	response	to	cold	
in	plantar	arteries	from	Trpm8	+/+	(n	=	6),	in	the	presence	of	BIBN	(n	=	5),	guanethidine	(n	=	4)	and	
both	blockers	(n	=	5).	
Furthermore,	 we	 confirmed	 that	 TRPA1	 and	 TRPM8	 channels	 are	 present	 in	 sympathetic	
neurons	by	detecting	mRNA	of	both	channels	in	isolated	superior	cervical	sympathetic	ganglia	
(SCG)	from	c57bl/6j	mice	(Figure	5.7A).	We	could	also	confirm	the	presence	of	perivascular	
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sympathetic	nerves	in	confocal	images	of	plantar	arteries	labelled	with	an	anti-TH	antibody	
(Figure	5.7B).	However,	we	could	not	detect	mRNA	expression	of	TRPA1	and	TRPM8	channels	
in	isolated	VSMC	from	plantar	arteries.	
These	 data	 suggest	 that	 cold	 has	 a	 dual	 action,	 a	 modest	 vasodilatory	 response	 through	
activation	of	TRPA1	and	TRPM8	channels	 in	sensory	nerve	endings,	and	a	dominant,	more	
potent	 vasoconstrictor	 response	 via	 the	 activation	 of	 TRPA1	 and	 TRPM8	 channels	 in	
sympathetic	nerve	endings.	Our	results	represent	the	first	evidence	for	an	intrinsic	response	
to	 cold	 in	 cutaneous	 arteries	 and	 for	 the	 functional	 role	 of	 sensory	 TRP	 channels	 in	
sympathetic	nerve	fibres.		
 
 
 
 
 
 
	
	
	
	
	
	
	
	
	
	
	
	
Figure	5.7.	Trpa1	and	Trpm8	mRNA	are	
present	in	superior	cervical	sympathetic	
ganglia	 from	 c57bl/6j	 plantar	 arteries.	
(A)	 Expression	 of	 TRPA1	 and	 TRPM8	
channels	 in	 cervical	 sympathetic	
neurons	 (B)	 Confocal	 images	 from	
c57bl/6j	plantar	artery	demonstrate	the	
presence	 of	 sympathetic	 fibres	 by	 the	
localization	 of	 Tyrosine	 hydroxylase,	
20X.	
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6.1	Discussion	
The	deregulation	of	the	vascular	function	under	external	stimuli	is	an	essential	process	that	
can	lead	to	cause	severe	vascular	disorders	and	even	sudden	death.	Resistance	arteries	can	
influence	intracellular	Ca2+	signaling	in	response	to	chemical	and	thermal	challenges	resulting	
in	the	modulation	of	vascular	tone.	Recent	findings	indicate	that	sensory	TRP	proteins	play	
important	roles	in	the	arterial	function	due	to	their	chemo-	and	thermosensory	properties,	
but	 their	actual	 relevance	to	vascular	physiology	remains	 fully	unknown.	Here,	we	provide	
evidence	 that	 sensory	 TRP	 channels	 are	 highly	 expressed	 in	 perivascular	 nerves	 and	 can	
regulate	the	vascular	tone	of	resistance	arteries	in	response	to	external	stimuli.	
6.1.1	Activation	of	 the	cation	channel	TRPM3	in	perivascular	nerves	 induces	
vasodilation	of	resistance	arteries	
TRP	 channels	 have	 been	 found	 in	 all	 cell	 types	 relevant	 for	 vascular	 function.	 Endothelial	
sensory	TRP	channels	regulate	angiogenesis	and	vascular	tone	and	permeability,	whereas	in	
VSMC	they	are	implicated	in	the	regulation	of	contraction	and	proliferation	[216].	Sensory	TRP	
channels	are	also	expressed	in	perivascular	cells,	such	as	TRPV4	in	astrocytes	and	TRPV1	and	
TRPA1	in	sensory	neurons	[217].	Therefore,	we	investigated	the	expression	and	functional	role	
of	the	emerging	sensory	TRPM3	channel	in	resistance	arteries.		
Although	we	found	Trpm3	mRNA	in	VSMC	and	adventitia	layer,	our	anatomical	and	functional	
data	 are	 consistent	with	 an	 expression	 of	 TRPM3	 protein	 restricted	 to	 perivascular	 nerve	
endings.	A	previous	report	showed	functional	expression	of	TRPM3	channels	in	proliferating	
human	 VSMC	 and	 in	 freshly	 isolated	 mouse	 aortic	 myocytes	 [128],	 but	 we	 did	 not	 find	
responses	to	PS	in	freshly	isolated	mouse	mesenteric	myocytes.	Whether	these	differences	
may	 reflect	 vascular	 bed-dependent	 functional	 expression	 of	 TRPM3	 requires	 further	
investigation.	Our	qPCR	studies	show	that	Trpm3	mRNA	expression	is	almost	40	times	higher	
in	aorta	than	in	mesenteric	arteries.	This	is	in	line	with	a	functional	expression	of	TRPM3	in	
aortic	VSMC,	whose	activation	leads	to	Ca2+	entry	and	vasoconstriction	[128].		
In	 contrast	 to	 these	 previous	 observations	 in	 aorta	 [128],	 we	 found	 that	 PS	 induced	
vasodilation	of	mesenteric	arteries.	The	maximal	effect	of	this	compound	was	comparable	to	
the	maximal	dilation	induced	by	nifedipine	or	a	Ca2+	free	solution.	A	previous	report	showed	
that	genetic	ablation	of	Trpm3	abolished	CGRP	release	from	skin	and	insulin	secretion	from	
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isolated	pancreatic	islets	in	response	to	100	μM	PS	[135].	However,	we	found	that	PS	induced	
dilation	via	two	components,	the	high	EC50	component	still	present	in	arteries	isolated	from	
Trpm3	 KO	mice.	 Our	 results	 show	 that	 PS	 has	 TRPM3-independent	 effects	 in	 mesenteric	
arteries	at	concentrations	higher	than	10	μM.	This	compound	has	been	shown	to	act	on	other	
targets,	 such	 as	 the	 gamma-aminobutyric	 acid	 receptor	 A	 and	 the	 N-methyl-D-aspartate	
receptor	[133],	but	it	is	not	yet	clear	whether	these	bare	any	relevance	in	mesenteric	arteries.	
Of	note,	the	values	of	the	EC50	and	Hill	coefficient	corresponding	to	the	TRPM3-independent	
PS	responses	were	different	in	c57bl/6j	and	Trpm3	KO	arteries.	This	may	be	due	to	the	fact	
that	in	c57bl/6j	arteries	the	TRPM3-dependent	processes	may	affect	the	TRPM3-independent	
vasodilation	observed	at	higher	PS	concentrations.	The	nonlinear	and	integrative	character	of	
the	 vasodilation	 process	 may	 preclude	 that	 the	 effects	 of	 individual	 PS-dependent	
components	add	up	in	a	simple	arithmetic	way.	Further	assessment	of	this	observation	will	be	
possible	once	the	mechanism	underlying	the	latter	component	is	clarified.	Nevertheless,	the	
data	 fitting	 results	 indicate	 that	 the	 TRPM3-dependent	 component	 contributes	 to	 an	
important	 fraction	 of	 the	 total	 PS	 induced	 dilation	 of	 c57bl/6j	 arteries	 (~60%),	 and	 its	
occurrence	in	the	lower	concentration	range	suggest	that	it	is	the	most	relevant	component	
in	physiological	conditions.		
In	 regard	 to	 the	 mechanism	 underlying	 TRPM3-dependent	 vasodilation,	 the	 overlap	 we	
observed	 between	 the	 PS	 dose	 response	 curves	 obtained	 for	 Trpm3	 KO	 arteries	 and	 for	
c57bl/6j	arteries	in	the	presence	of	the	CGRP	receptor	inhibitor	suggests	that	PS-induced	CGRP	
effects	are	fully	mediated	by	TRPM3.	Previous	studies	demonstrated	CGRP	release	upon	TRP	
channel	activation	in	mouse	trachea	[218]	and	hind	paw	skin [135].	However,	we	were	unable	
to	 detect	 CGRP	 release	 from	mesenteric	 using	 similar	 experimental	 procedures	 (data	 not	
shown),	most	likely	because	our	preparation	is	between	~200	and	2000	fold	smaller	than	the	
trachea	and	skin	ones,	respectively. 
The	 mechanisms	 proposed	 for	 the	 vasodilating	 effects	 of	 CGRP	 include	 an	 endothelium-
dependent	component,	whereby	activation	of	the	endothelial	CGRP	receptor	results	in	a	rise	
in	cAMP,	NO	production	and	guanylate	cyclase-mediated	vasodilation	[219].	In	addition,	there	
are	two	effects	mediated	by	AC	and	PKA	stimulation	in	VSMC:	activation	of	K+	channels	and	
stimulation	of	myosin	light	chain	phosphatase	[19,	220].	Our	data	are	consistent	with	all	these	
mechanisms,	 as	 we	 found	 that	 the	 responses	 to	 PS	 were	 enhanced	 in	 the	 presence	 of	
endothelium	and	were	partially	inhibited	by	a	cocktail	of	K+	channel	blockers.	
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Furthermore,	we	could	exclude	a	possible	contribution	of	sympathetic	fibres	to	the	PS	induced	
vasodilation	 mechanisms.	 Our	 data	 exclude	 both	 the	 functional	 contribution	 of	 β2-
adrenoreceptors	to	the	sympathetic	response	and	the	involvement	of	these	receptors	in	the	
vasodilation	induced	by	PS	application,	as	no	differences	were	observed	when	we	applied	the	
β-blocker	propranolol.	Moreover,	the	absence	of	colocalization	of	TH	and	β-gal	in	the	nerve	
fibres	 innervating	 the	media	 layer	 indicates	 a	 lack	of	 expression	of	 TRPM3	 in	 sympathetic	
nerve	endings.		
Notably,	it	was	previously	shown	that	CGRP-containing	fibres	and	TH-containing	fibres	can	be	
found	in	close	proximity	of	each	other	in	mouse	mesenteric	arteries,	and	that	the	former	run	
further	away	from	the	VSMC	[221],	as	we	found	for	TRPM3-	and	b-gal-expressing	nerves.	
Notably,	 the	 vasodilation	 we	 report	 here	 is	 the	 most	 sensitive	 TRPM3-mediated	 tissue	
response	to	PS	reported	so	far.	Previous	studies	showed	TRPM3-dependent	effects	of	PS	in	
the	range	of	tens	to	hundreds	of	micromolar,	e.g.,	insulin	release	from	pancreatic	islets	[130],	
CGRP	release	from	mouse	skin	preparations	[135]	and	rat	ductus	arteriosus	contraction [222].	
In	contrast,	we	 found	significant	TRPM3-dependent	vasodilation	with	an	EC50	of	7.7	μM	 in	
intact	arteries.	This	value	 is	similar	 to	those	reported	for	stimulation	of	TRPM3	currents	 in	
vitro	(5	-	23	μM)	[124,	134].	Most	likely,	this	is	a	consequence	of	the	technical	approach	in	
myography	experiments	since	PS	has	direct	access	to	the	TRPM3-expressing	nerve	endings,	
which	contrasts	with	other	preparations	in	which	structural	barriers	are	expected	to	interfere	
with	PS	diffusion.	This	suggests	the	mesenteric	artery	preparation	as	very	 instrumental	 for	
studies	on	TRPM3	modulation	and	pharmacology,	 including	the	testing	of	the	specificity	of	
previously	 described	 channel	 inhibitors	 [129,	 139],	 in	 a	 close-to-physiological	 context.	 In	
addition,	 our	 results	 shed	 light	 on	 the	 long-standing	 question	 of	whether	 PS	 is	 after	 all	 a	
physiological	 endogenous	 agonist	 of	 TRPM3	 [130].	 We	 observed	 TRPM3-dependent	
vasodilation	 induced	by	PS	 in	the	 low	micromolar	range,	which	matches	PS	concentrations	
that	may	be	present	in	living	tissues	[130].	The	physiological	or	pathological	contexts	in	which	
PS	reaches	such	concentrations	in	mesenteric	tissue	remain,	however,	elusive.	
The	 idea	 that	 TRPM3	 activation	 induces	 vasodilation	 in	 mesenteric	 arteries	 is	 further	
supported	by	the	potent	effect	of	the	synthetic	agonist	CIM0216.	However,	this	compound	
proved	 to	be	not	 fully	 specific	 for	 this	channel,	as	 it	also	produced	vasodilation	 in	arteries	
dissected	from	Trpm3	KO	mice	at	concentrations	above	~0.1	μM.	We	argue,	therefore,	that	
CIM0216	may	be	used	as	a	pharmacological	tool	to	further	investigate	the	role	of	TRPM3	in	
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mesenteric	arteries	below	these	concentrations.	Because	this	is	a	synthetic	compound	with	
no	 obvious	 similarity	 to	 any	 other	 known	 TRPM3	 modulator	 [135],	 we	 consider	 that	
investigating	the	TRPM3-independent	effects	 is	 interesting.	Nevertheless,	 reporting	 for	 the	
first	time	that	CIM0216	has	off-target	effects	is	of	great	value	for	future	research	on	TRPM3	
pathophysiology.		
The	functional	expression	of	TRPM3	in	nociceptive	neurons	and	its	contribution	to	noxious	
heat	sensing [62]	may	suggest	that	the	function	of	this	channel	in	mesenteric	arteries	is	the	
detection	 of	 noxious	 stimuli	 generated	 in	 pathological	 conditions.	 The	 high	 temperatures	
required	for	TRPM3	activation	[62]	strongly	indicate	that	heat	may	not	be	a	relevant	stimulus	
of	 TRPM3	 in	mesenteric	 preparations.	 Nevertheless,	 it	 would	 be	 interesting	 to	 determine	
whether	this	channel	is	implicated	in	responses	of	skin	resistance	arteries	to	heat.	However,	
in	contrast	 to	previous	 reports	 in	skin	and	 trachea [62],	we	show	here	a	 role	of	TRPM3	 in	
sensory	fibres	innervating	a	tissue	that	is	not	directly	accessible	to	external	stimuli.	This	may	
indicate	that	TRPM3	functions	as	detector	of	endogenous	compounds	released	upon	tissue	
damage	and/or	metabolic	deregulation.	Two	other	sensory	TRP	channels,	TRPV1	and	TRPA1	
are	 proposed	 to	 act	 as	 receptors	 of	 danger-	 and	 pathogen-associated	molecular	 patterns	
during	tissue	injury	and	inflammatory	diseases	[223],	by	detecting	acidosis,	reactive	oxygen	
and	 nitrogen	 species,	 electrophilic	 compounds	 and	 bacterial	 endotoxins [101,	 224-226].	
However,	 TRPV1	 and	 TRPA1	 have	 also	 been	 reported	 in	 VSMC	 and	 endothelial	 cells	 of	
resistance	 arteries,	 respectively [99,	 113,	 114,	 227,	 228].	 Thus,	 according	 to	 our	 findings,	
TRPM3	is	the	only	one	of	these	sensory	TRP	channels	exclusively	functional	 in	perivascular	
nerves.	 This	 suggests	 TRPM3	 as	 the	 most	 specific	 target	 to	 trigger	 resistance	 artery	
vasodilation	via	stimulation	of	the	perivascular	sensory	innervation.	
We	conclude	that	in	contrast	to	what	was	previously	reported	in	aorta	[128],	in	mesenteric	
arteries	 TRPM3	 is	 functionally	 expressed	 mainly	 in	 perivascular	 nerve	 endings	 and	 its	
activation	 leads	 to	vasodilation	rather	 than	contraction	 (Figure	6.1).	Our	data	 is	consistent	
with	a	model	in	which	activation	of	TRPM3	triggers	CGRP	release,	leading	to	vasodilation	via	
endothelium-dependent	and	endothelium-independent	pathways.	We	propose	that,	together	
with	TRPV1	and	TRPA1,	TRPM3	allows	mesenteric	arteries	to	react	to	a	wide	range	of	damage-
associated	molecules,	leading	to	vasodilation,	via	the	common	pathway	of	CGRP	release	from	
perivascular	sensory	nerve	endings.	
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Figure	6.1.	Proposed	vasodilation-induced	TRPM3	pathway	in	resistance	arteries.	Activation	of	TRPM3	
channels	by	PS	leads	to	K+	channel	activation	causing	vasodilation,	via	the	common	pathway	of	CGRP	
release	from	perivascular	sensory	nerve	endings.	
 
6.1.2	Role	of	TRPA1	and	TRPM8	channels	in	intrinsic	vascular	responses	to	cold	
Our	results	provide	evidence	that	TRPA1	and	TRPM8	channels	are	essential	vascular	sensors	
of	cold,	playing	a	significant	role	in	a	local	vascular	response	to	cold	temperatures	in	isolated	
arteries	when	the	CNS	is	not	mediating	the	response.	Human	studies	have	already	described	
a	 cold	 systemic	 reflex	 at	 very	 low	 temperatures	 (<	 15	 oC);	 however,	 if	 these	 channels	 are	
present	in	peripheral	nerves	endings	in	the	adventitia	of	the	vessels,	they	could	also	modulate	
the	 cutaneous	 circulation	 in	 response	 to	 local	 temperature	 changes	 as	 a	 protective	
mechanism.	 Therefore,	 in	 this	 study,	we	used	a	 cold	 exposure	model	 to	measure	 intrinsic	
responses	after	 local	 cooling	exposure	of	 isolated	plantar	arteries	 from	KO	mice	and	 their	
corresponding	 controls.	 Immediately	 after	 local	 cold	 exposure	 of	 plantar	 arteries	 from	
c57bl/6j	mice	(10	oC	for	at	least	5	min),	a	decreased	in	the	diameter	was	observed,	that	was	
fully	reverted	back	to	baseline	levels	when	returning	to	the	initial	temperature	(37	oC).		
The	 local	 cold-induced	 vascular	 response	 found	 in	 this	 study	 did	 not	 involve	 the	 reported	
Hunting	reaction,	which	induces	vasodilation	in	response	to	cold	stimulus	and	is	characterized	
by	subsequent	vasoconstrictions	and	vasodilations	during	the	cooling	phase	[176].		
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Deletion	of	both	TRPV4	and	TRPM3	channels,	suggested	as	environmental	thermosensors,	did	
not	affect	the	response	to	cold,	consistent	with	the	knowledge	that	these	channels	have	been	
reported	to	play	a	role	as	heat	sensors	[62,	215].	However,	the	role	of	TRPA1	in	cold	sensation	
is	still	a	big	debate	in	literature.	Several	studies	have	shown	an	indirect	activation	of	TRPA1	
channel	 under	 low	 temperatures	 [180].	 The	 first	 evidence	 of	 the	 role	 of	 TRPA1	 in	 cold	
sensitivity	was	shown	in	CHO	cells	transfected	with	TRPA1 [91],	but	other	groups	were	unable	
to	reproduce	similar	data	in	HEK293	cells	[77].	Also,	while	Munns	et	al.	showed	no	correlation	
between	 TRPA1	 and	 cold	 temperature	 in	 cultured	 DRG	 neurons	 [229],	 other	 groups	 have	
demonstrated	that	DRG	neurons	are	cold	sensitive	via	TRPA1	activation [92].	Several	reasons	
have	been	proposed	for	the	different	findings	between	studies,	such	as	different	cell	types	
and	methodologies.	In	spite	of	some	discrepancies,	it	seems	that	there	is	substantial	evidence	
for	a	role	of	TRPA1	as	a	cold	sensor.	However,	we	do	not	know	many	details	regarding	the	
mechanisms	 and	 the	 functional	 contribution	 of	 this	 channel	 in	 physiological	 and	
pathophysiological	 situations.	 In	 particular,	 the	 knowledge	 and	 understanding	 of	 TRPA1	
contribution	 to	 cold-induced	 vascular	 response	 is	 still	 at	 an	 early	 stage.	 Karashima	 et	 al.	
showed	that	cold-induced	nociceptive	behavior	in	mice	is	TRPA1-dependent	[181].	TRPA1	has	
been	 proposed	 to	 play	 an	 essential	 role	 in	 the	mechanisms	 involved	 in	 systemic	 vascular	
responses	induced	by	cold	[190].	In	this	line,	we	demonstrated	that	algo	the	intrinsic	vascular	
response	to	cold	is	modulated	by	TRPA1	activation.	The	cold-induced	vasoconstriction	found	
in	 precontracted	 isolated	 plantar	 arteries,	 exposed	 to	 low	 temperatures	 (10	 oC),	 was	
substantially	reduced	in	Trpa1	KO	plantar	arteries	and	in	c57bl/6j	pretreated	with	the	TRPA1	
antagonist	HC030031.	
Another	interesting	point	of	debate	is	the	comparison	of	the	responses	to	cold	of	TRPA1	and	
TRPM8	channels.	 It	has	been	suggested	that	both	are	cold	sensors	that	could	differ	on	the	
range	of	activating	temperatures:	while	TRPA1	would	be	responsible	 for	sensing	a	noxious	
cold	range,	TRPM8	is	suggested	to	sense	innocuous	cool	temperature	[230].	In	addition,	it	has	
been	reported	that	TRPM8	expressed	on	sensory	neurons	mediates	the	response	to	deep	
body	 cooling	 which	 is	 associated	 with	 cutaneous	 vasoconstriction	 [191].	 In	 this	 line,	
Reimundez	 et	 al.	 showed	 that	 Trpm8	 KO	 mice	 exhibited	 a	 fall	 of	 0.7°C	 in	 core	 body	
temperature	when	housed	at	cold	temperatures	and	TRPM8	deficiency	induced	an	increase	
in	 tail	 heat	 loss	 demonstrating	 that	 TRPM8	 is	 required	 for	 a	 precise	 thermoregulation	 in	
response	to	cold [231].	Although,	the	control	of	body	temperature	in	the	systemic	response	
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is	 thought	 to	 be	 the	 main	 factor	 regulating	 blood	 flow	 in	 the	 cutaneous	 circulation.	 We	
decided	to	investigate	the	contribution	of	TRPM8	channels	to	the	local	vascular	response	to	
cold.	We	found	that	in	TRPM8	+/+	mice,	cold	was	able	to	produce	a	significant	vasoconstriction	
in	 isolated	plantar	arteries,	and	this	response	was	decreased	 in	Trpm8	KO	plantar	arteries.	
This	 suggests	 that	 TRPM8	 is	 also	 involved	 in	 the	 intrinsic	 cold-induced	 vascular	 response	
affecting	the	cutaneous	circulation	without	the	presence	of	the	CNS.	Our	ex	vivo	approach	
does	not	allow	us	to	explore	the	relative	contribution	of	these	channels	(TRPA1	and	TRPM8)	
to	both	intrinsic	and	systemic	responses	to	cold,	so	that	we	cannot	determine	the	effect	of	
TRPA1	and	TRPM8	channels	in	thermoregulatory	responses.	However,	we	provided	evidence	
of	a	local	role	of	these	channels	in	cold-induced	vascular	responses.	The	fact	that	the	outcome	
of	this	local	response	is	also	a	vasoconstriction	suggest	that	both	local	and	global	contributions	
of	TRPA1	and	TRPM8	to	cold-induced	vascular	response	are	additive,	so	that	local	mechanisms	
can	 reinforce	 systemic	 reflexes,	 contributing	 in	 a	 more	 direct	 and	 fast	 way	 to	 vascular	
reactivity	in	response	to	temperature	changes.	
TRPM8	and	TRPA1	channels	have	been	proposed	to	be	coexpressed	in	the	same	neurons.	For	
instance,	in	cultured	DRG,	a	population	of	cells	has	been	reported	to	be	sensitive	to	the	TRPA1	
and	TRPM8	channels	agonists	mustard	oil	and	menthol	[232].	In	another	study,	20%	of	TRPA1-
positive	neurons	also	express	TRPM8	[233].	Using	Trpm8	KO	plantar	arteries	in	the	presence	
of	the	TRPA1	antagonist	(HC030031),	we	showed	that	the	cold-induced	vasoconstriction	was	
completely	 abolished.	Altogether,	 these	 results	 confirmed	 that	 local	 cold-induced	 vascular	
response	 is	mediated	 via	 both	 cold	 thermo-TRP	 channels	 TRPA1	 and	 TRPM8	 located	 in	 a	
subset	 of	 perivascular	 nerves,	 and	 that	 these	 channels	 work	 in	 a	 synergistic	 manner	 to	
mediate	vasoconstriction.	This	additive	effect	could	be	explained	by	the	activation	of	these	
channels	in	a	different	range	of	low	temperatures,	so	that	TRPM8	would	be	activated	under	
mild	 cooling	 temperatures,	 while	 lower	 temperatures	 would	 recruit	 TRPA1	 channels.	 In	
agreement	with	this,	Winter	et	al.	[196]	found	that	these	channels	are	responsible	to	influence	
the	behavioral	 responses	over	 the	entire	 cold	 temperature	 range.	However,	 it	 is	not	 clear	
whether	TRPM8	is	involved	in	both	innocuous	and/or noxious	cold	transduction.	Bautista	et	
al.	showed	that	Trpm8	KO	mice	display	no	preference	for	warm	surface	under	temperatures	
down	to	15	oC,	suggesting	that	mice	 lacking	TRPM8	channels	cannot	discriminate	between	
warm	and	innocuous	cool	temperature;	however,	when	the	temperature	drop	into	a	noxious	
range	(5-10	oC),	Trpm8	KO	mice	display	a	preference	for	the	warm	side	[150].	These	findings	
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were	 supported	 by	 Dhaka	 et	 al.	 suggesting	 not	 only	 a	 TRPM8-dependent	 mechanism	 for	
innocuous	 cold	 sensation,	 but	 also	 the	 presence	 of	 a	 TRPM8-independent	mechanism	 for	
noxious	 cold	 transduction	 [152].	 In	 accordance	 with	 this,	 Pan	 et	 al.	 have	 reported	 that	
activation	of	both	channels	by	using	a	copper	cold	probe	(5	oC)	affect	the	blood	flow	under	
localized	cold	conditions;	however,	neither	the	TRPA1	antagonist	nor	the	TRPM8	antagonist	
had	effects	 in	modulating	 the	blood	 flow	response	 induced	by	 the	 localized	cooling	of	 the	
mouse	 paw.	 Intriguingly,	 other	 cold-	 sensing	 mechanisms	 have	 been	 suggested	 that	 are	
independent	of	TRPA1	and	TRPM8	[229].  
In	 contrast,	we	 showed	 a	 prominent	 role	 of	 TRPA1	 and	 TRPM8	 expressed	 in	 sympathetic	
neurons	in	mediating	the	cold	vascular	response	at	a	noxious	cold	range.	However,	whether	
TRPM8	 channels	 can	 also	 be	 influenced	 in	 the	 innocuous	 cold	 range	 requires	 further	
investigation.	The	study	in	our	experimental	conditions	of	the	effect	of	vessel	diameter	of	a	
range	of	temperatures	between	25	and	10	oC,	to	determine	the	degree	of	activation	of	both	
TRPM8	and	TRPA1	channels	could	help	to	check	this	hypothesis.	 
The	relative	contribution	of	sensory	and	sympathetic	nerves	to	this	local	response	to	cold	
is	difficult	to	determine.	 It	 is	known	that	they	have	a	similar	distribution	pattern	around	
blood	vessels	in	the	adventitial	layer	and	an	influence	between	the	two	nerve	subsets	was	
shown	 after	 denervation	 of	 sensory	 peptide-	 or	 catecholamine-containing	 sympathetic	
nerves	[234].	In	this	study,	we	pretreated	c57bl/6j	plantar	arteries	with	BIBN,	a	well-known	
CGRP	receptor	antagonist	used	for	the	treatment	of	migraine [23]	and	we	found	a	significantly	
increase	of	the	vasoconstrictor	response,	 implying	the	 involvement	of	sensory	perivascular	
nerves	in	the	local	vascular	response	to	cold.	On	the	other	hand,	superficial	vessels	exhibit	a-
adrenoreceptors	mediated	peripheral	vasoconstriction	during	exposures	to	low	temperatures	
[235,	236].	 Using	 a	 pharmacological	 blockade	 of	 catecholamine	 release	 by	 guanethidine	
caused	 not	 only	 an	 inhibitory	 effect	 on	 the	 cold-induced	 vasoconstriction	 but	 also	 a	
significant	vasodilation	in	response	to	cold.		
Altogether,	our	data	indicated	the	contribution	of	TRPM8	and	TRPA1	channels	located	in	
both	sensory	and	sympathetic	nerve	endings	to	this	intrinsic	cold-induced	response.	
While	the	expression	of	these	channels	in	sensory	nerve	endings	is	well	documented,	the	
data	in	the	literature	regarding	the	presence	of	TRPA1	and	TRPM8	in	sympathetic	nerves	
and	their	functional	role	is	scarce	and	far	from	being	conclusive.	Smith	et	al.	suggested	that	
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the	sympathetic	nervous	system	mediated	by	the	activation	of	TRPA1	may	play	a	direct	role	
in	sympathetic	responses	to	cold	temperatures.	Using	Ca2+	 imaging,	 they	have	 revealed	a	
population	of	neurons	in	the	SCG	of	the	mouse	that	respond	to	cooling	but	were	insensitive	
to	menthol	[237].	In	another	study	from	the	same	group,	they	found	that	cold	sensitivity	in	
sympathetic	neurons	and	sensory	neurons	can	be	generated	 in	the	absence	of	TRPM8	and	
TRPA1	after	the	followed	application	of	agonists	[229].	In	our	study,	we	were	able	to	detect	
Trpa1	 and	 Trpm8	 mRNA	 expression	 in	 isolated	 SCG	 from	 c57bl/6j.	 In	 addition,	 we	
demonstrated	 that	 the	 local	 vasoconstrictor	 response	 is	dominated	by	 the	activation	by	
cold	of	TRPA1	and	TRPM8	channels	located	in	the	sympathetic	nerve	endings.	Finally,	we	
showed	that	this	cold-induced	vascular	response	was	fully	abolished	when	blocking	both	
TRPA1	and	TRPM8	receptors.	Altogether,	these	data	suggest	that	sympathetic	fibers	play	
an	 essential	 role	 into	 the	 intrinsic	 cold-induced	 vascular	 reactivity	 and	 that	 TRPA1	 and	
TRPM8	channels	are	fully	mediating	this	vascular	response.	
 
 
Figure	6.2.	Proposed	cold-induced	vascular	response	pathway	in	plantar	arteries.	Activation	of	TRPA1	
and	TRPM8	channels	by	cold	stimulus	leads	to	vasoconstriction	of	plantar	arteries	via	the	release	of	
neuropeptides	by	sensory	and	sympathetic	nerves. 
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Collectively,	 these	 novel	 evidences	 revealed	 an	 important	 role	 of	 TRPA1	 and	 TRPM8	
channels	in	mediating	the	vascular	response	to	local	cold	exposure	in	isolated	cutaneous	
arteries	 without	 the	 involvement	 of	 the	 CNS.	 Their	 activation	 by	 low	 temperatures	 is	
compatible	with	a	dual	mechanism	in	which	TRPA1	and	TRPM8	channels	are	expressed	in	
both	sympathetic	and	sensory	neurons	and	lead	to	antagonist	effects	through	the	release	
of	neurotransmitters	from	both	types	of	fibres	and	resulting	in	a	global	vasocontriction	of	
the	artery	(Figure	6.2).	Our	results	demonstrate	the	presence	of	TRPA1	and	TRPM8	channels	
not	only	in	afferent	(sensory)	fibres	but	also	in	efferent	(sympathetic)	nerve	fibres	and	provide	
the	first	direct	evidence	for	an	intrinsic	local	response	to	cold	in	isolated	cutaneous	arteries.	
Due	to	their	 location	 in	sympathetic	nerve	endings	and	their	relevant	contribution	to	cold-
induced	vasoconstriction	it	is	tempting	to	speculate	that	these	channels	may	be	relevant	in	
the	development	of	diseases	such	as	Raynaud’s	disease	in	which	low	temperatures	induces	a	
robust	vasoconstriction	of	the	peripheral	blood	vessels	via	activation	of	sympathetic	nerves	
leading	to	hypoxia	tissue [238].		
Since,	 avoiding	 sudden	 cold	 and	 rapid	 changes	 in	 temperature	 are	 the	 primary	 therapies	
recommended	until	now [239].	TRPA1	and	TRPM8	channels	could	represent	novel	targets	for	
the	development	of	therapies	directed	to	attenuate	sympathetic	vasoconstriction.		
6.2	General	conclusions	
Although	several	sensory	TRP	channels	have	been	implicated	in	the	regulation	of	the	vascular	
tone	via	multiple	mechanisms,	 the	role	of	 the	sensory	TRPM3	channel	 in	vascular	 function	
remains	unknown.	We	found	that,	contrary	to	what	was	reported	for	aorta	[128],	PS	induces	
vasodilation	of	mesenteric	arteries,	and	that	these	effects	are	partly	mediated	by	activation	
of	TRPM3,	via	release	of	CGRP	and	subsequent	activation	of	K+	channels	in	VSMC.	Our	data	
support	a	contribution	of	TRPM3	as	a	potential	therapeutic	target	for	the	modulation	of	the	
tone	 of	 resistance	 arteries	 and	 as	 a	 plausible	 effector	 of	 endogenous	 damage-associated	
molecules	mediating	protective	responses	in	these	vascular	beds.		
On	the	other	hand,	vascular	functions	of	the	sensory	TRP	channels	have	been	also	associated	
with	their	thermo-properties [179].	In	this	sense,	we	found	that	TRPA1	and	TRPM8	channels	
have	a	key	role	in	the	local	cold-induced	vascular	response.	Using	myography	experiments	to	
determine	changes	in	vessel	diameter,	we	could	identify	these	channels	both	in	sensory	and	
sympathetic	 nerve	 endings,	 and	 we	 could	 conclude	 that	 the	 global	 cold-induced	
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vasoconstriction	observed	in	the	plantar	artery	 is	the	sum	of	a	small	vasodilatory	response	
(due	 to	activation	of	 these	channels	 in	 sensory	nerve	endings)	and	a	 large	vasoconstrictor	
response	(due	to	the	activation	of	the	channels	present	in	sympathetic	nerve	endings).	These	
results	represent	the	first	evidence	for	an	intrinsic	response	to	cold	in	cutaneous	arteries	and	
for	the	presence	and	the	functional	role	of	sensory	TRP	channels	in	efferent	nerve	fibers.		
6.3	Future	perspectives	
6.3.1	Role	of	TRPM3	in	hypertension. 
Hypertension	 remains	 an	 important	 public	 health	 concern	 and	 a	major-medical	 challenge,	
being	 one	 of	 the	 most	 important	 risk	 factor	 for	 heart	 disease	 and	 stroke	 and	 carrying	
significant	 mortality	 and	 morbidity.	 It	 has	 been	 found	 that	 this	 disease	 is	 associated	 to	
alterations	in	the	function	of	the	vasculature	(myogenic	response)	[240,	241].	However,	the	
mechanisms	underlying	blood	pressure	deregulation	are	not	fully	understood.		
The	contribution	of	TRPM3	to	systemic	blood	pressure	regulation	is	difficult	to	predict,	since	
activation	of	TRPM3	was	also	reported	to	increase	the	tone	of	mouse	aorta	[128].	Preliminary	
data	demonstrated	that	Trpm3	KO	mice	to	be	slightly	but	consistently	hypotensive	compared	
to	 c57bl/6j	 mice	 (Figure	 6.3),	 indicating	 that	 TRPM3	 contributes	 to	mean	 blood	 pressure	
regulation	and	that	the	overall	contribution	of	TRPM3	channels	in	physiological	conditions	is	
to	increase	the	vascular	tone.	Using	a	mouse	model	of	AngII-induced	hypertension	we	found	
that	AngII	infusion	induced	an	overt	hypertensive	phenotype	in	c57bl/6j	mice	but	very	much	
surprisingly,	not	in	Trpm3	KO	mice	(Figure	6.4).												
Notably,	TRPM3	is	abundantly	expressed	in	the	kidneys [123],	where	are	known	to	regulate	
the	hypertensive	effects	of	AngII.	Therefore,	this	suggest	a	role	of	this	channel	in	mesenteric	
and	 renal	 arteries	 in	 the	 pathogenesis	 of	 hypertension.	 The	 future	 perspectives	 aim	 at	
understanding	the	role	of	TRPM3	in	hypertension.	
To	 accomplish	 this,	we	propose	 to	determine	 the	expression	profile	of	 TRP	and	especially	
TRPM3	in	renal	arteries	 from	c57bl/6j	and	Trpm3	KO	mice.	This	should	be	done	 in	mice	 in	
which	hypertension	will	be	induced	via	osmotic	minipumps	loaded	with	AngII	(or	saline	for	
producing	 control	 animals	 for	 comparison).	 Real-time	 qPCR	 experiments	 and	 anatomical	
localization	studies	using	immunofluorescence	confocal	microscopy	could	help	to	assess	the	
levels	of	TRPM3	functional	expression	in	renal	arteries.	
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Figure	 6.3.	 Box	 plot	 and	 individual	 systolic,	 diastolic,	 mean	 blood	 pressure	 and	 heart	 rate	
measurements	in	c57bl/6j	mice	(n	=	30)	and	Trpm3	KO	mice	(n	=	25).	Each	data	point	is	the	average	of	
value	obtained	in	different	sessions	with	30	measurements	per	session.	*	indicates	P	<	0.05	for	the	
comparison	between	groups. 
Patch-clamp	 experiments	 in	 VSMC	 using	 TRPM3	 agonists	 could	 serve	 to	 confirm	 the	
localization	data	at	a	functional	level.		In	order	to	characterize	the	mechanism	underlying	in	
the	effect	of	TRPM3-induced	under	hypertensive	 conditions	by	AngII,	pressure	myography	
experiments	in	renal	arteries	isolated	from	c57bl/6j	and	Trpm3	KO	mice	need	to	be	performed	
in	normal	condition	and	after	AngII-induced	hypertension.	This	would	help	us	to	elucidate	the	
mechanism	underlying	the	key	role	of	TRPM3	and	test	whether	this	channel	serves	as	a	novel	
therapeutic	target	for	the	treatment	of	high	blood	pressure.	
Another	important	aspect	is	the	expression	of	TRP	channels	in	the	context	of	remodelling	of	
VSMC	in	AngII-induced	hypertension.	During	the	progression	of	hypertension	VSMC	undergo	
processes	 of	 structural	 remodelling,	 characterized	 by	 a	 transition	 from	 contractile	 to	
proliferative	phenotypes	[242].	Therefore,	qPCR	experiments	in	freshly	isolated	renal	VSMC	
(contractile	phenotype)	and	cultured	renal	VSMC	(proliferative	phenotype)	would	determine	
the	 TRP	 channel	 expression	 pattern	 in	 hypertensive	 and	 control	 mice	 giving	 us	 an	 idea	
whether	other	TRP	channels	are	involved	in	the	process	of	vascular	remodelling	induced	by	
hypertension	and	therefore	to	establish	new	lines	of	research.		
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Figure	6.4.	 Individual	mean	blood	pressure	measurements	before	and	after	7	days’	 treatment	with	
control	saline	or	angiotensin	in	c57bl/6j	(n	=	9)	and	Trpm3	KO	(n	=	5)	mice.	*	indicates	P	<	0.05	for	the	
comparison	of	the	data	collected	before	and	after	treatment,	paired	t-test.		
6.3.2	 Cold	 shock	 response	 in	 ‘in	 vivo’	 models:	 role	 of	 TRPA1	 and	 TRPM8	
channels		
Cold	shock	response	is	the	physiological	response	to	sudden	cold,	especially	cold	water.	It	lasts	
for	only	1	minute	after	entering	the	water.	In	humans,	cold	sock	response	is	the	most	common	
cause	of	death	from	accidentally	falling	or	voluntary	immersion	in	very	cold	water.	The	first	
reactions	after	the	immediate	shock	of	cold	are	an	automatic	gasp	reflex	in	response	to	rapid	
skin	cooling	and	hyperventilation [243].	It	also	induces	heart	attack,	especially	in	people	with	
existing	 cardiovascular	diseases,	due	 to	 the	heart	has	 to	pump	 the	 same	volume	of	blood	
through	the	body.	Cold	shock	response	has	been	associated	with	a	robust	vasoconstriction	of	
the	peripheral	arteries [244],	however,	the	molecular	targets	and	the	mechanisms	underlying	
this	cold-induced	systemic	response	are	not	fully	understood.		
TRPM8	has	been	identified	as	an	essential	receptor	for	initiating	the	cold	shock	response	in	
testes [245].	These	results	together	with	our	preliminary	data	showing	a	role	of	TRPA1	and	
TRPM8	 in	 response	 to	 cold	 in	 isolated	 peripheral	 arteries	 suggest	 that	 these	 sensory	 TRP	
channels	could	be	also	involved	in	the	vascular	cold	shock	response.	Therefore,	the	second	
aim	of	 the	 future	perspectives	would	be	to	 investigate	the	 influence	of	TRPA1	and	TRPM8	
channels	in	the	hemodynamic	responses	to	fast	cold	application	in	´in	vivo´	models.		
First,	we	propose	to	challenge	Trpa1	KO,	Trpm8	KO	mice	and	their	corresponding	controls	to	
noxious	 cold	water	 (10	 oC),	 by	 immersion	 during	 30	 seconds	while	 heart	 rate	 and	 arterial	
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pressure	are	measured	by	telemetry	system	in	conscious	mice.	This	system	requires	a	surgical	
implantation	of	a	catheter	 into	the	 left	carotid	artery	of	 the	mouse	which	 is	attached	to	a	
combination	pressure	transducer,	transmitter	and	battery,	all	encapsulated	in	an	implantable	
microminiaturized	electronic	monitor	which	is	placed	subcutaneously	in	the	mouse.	We	would	
also	use	different	pharmacological	tools	including	channel	antagonists	and	blockers	of	both	
sympathetic	and	sensory	nerves	that	could	serve	to	confirm	the	implication	of	both	nervous	
systems.	
Next,	we	could	also	determine	whether	noxious	cold	stimulus	´in	vivo´	activates	TRPA1	and	
TRPM8	channels	by	using	the	non-invasively,	computerized	tail-cuff	system.	Measurements	
of	 systolic	 and	 diastolic	 pressure	 and	 heart	 rate	 of	 trpa1	 KO,	 trpm8	 KO	 mice	 and	 their	
corresponding	 controls	 would	 be	 acquired	 while	 awake	 animals	 are	 placed	 in	 plastic	
restrainers.	A	cuff	with	a	pneumatic	pulse	sensor	would	be	attached	to	the	tail.	First,	they	will	
be	kept	warm	in	a	platform	heated	to	32-35	°C	for	5	minutes	and	afterwards	on	frozen	blocks	
during	 1	 minute.	 To	 obtain	 appropriate	 blood	 pressure	 and	 heart	 rate	 estimations,	 the	
measurements	would	be	carried	out	in	at	least	three	different	days,	and	20-40	consecutive	
measurements	 would	 be	 obtained	 in	 each	 session	 from	 each	 animal.	 We	 would	 use	
pharmacological	approaches	to	elucidate	the	mechanism	underlying	the	cold	response.	
Altogether,	these	future	perspectives	will	give	us	some	ideas	about	the	mechanism	underlying	
the	fast-cold	application	response	and	whether	TRPA1	and	TRPM8	channels	are	involved	in	
the	hemodynamic	responses	´in	vivo´	induced	by	noxious	cold	application.		
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8.1	Abstract	
The	regulation	of	the	blood	pressure	is	an	essential	physiological	process	mainly	regulated	by	
the	vascular	tone	that	is	dependent	on	the	function	of	multiple	ion	channels	that	determine	
the	 dynamics	 of	 intracellular	 Ca2+	 concentration	 in	 VSMC,	 endothelial	 cells,	 as	 well	 as	 in	
perivascular	 nerves.	 Recent	 studies	 indicate	 that	 sensory	 TRP	 channels	 expressed	 in	
perivascular	nerves	may	be	implicated	in	the	mechanisms	underlying	arterial	tone	regulation	
through	the	release	of	many	factors	such	as	CGRP	and	NA	due	to	their	capacity	to	influence	
cellular	excitability	and	intracellular	Ca2+	signaling.	The	vascular	function	of	these	channels	has	
been	associated	to	their	chemo-	and	thermosensory	properties,	but	their	actual	relevance	to	
vascular	tone	regulation	under	external	stimuli	remain	unknown.		
Within	the	TRPM	family,	the	role	of	TRPM3	channels	in	the	contribution	to	vascular	tone	in	
resistance	arteries	has	not	been	yet	stablished.	Therefore,	using	anatomical	 localization	by	
immunofluorescence	microscopy	in	intact	resistance	arteries	and	patch-clamp	recordings	in	
isolated	 VSMC,	 we	 found	 that	 TRPM3	 expression	 in	 mesenteric	 arteries	 is	 restricted	 to	
perivascular	 sensory	 nerves.	 Pressure	 myography	 experiments	 showed	 that	 chemical	
activation	of	TRPM3	channels	 in	mesenteric	arteries	by	an	endogenous	steroid	PS	 leads	to	
vasodilatation,	 via	 CGRP	 release	 from	 perivascular	 sensory	 nerves.	 This	 data	 support	 the	
contribution	of	TRPM3	as	a	potential	therapeutic	target	for	the	modulation	of	the	resistance	
arteries	 tone	 and	 as	 a	 plausible	 effector	 of	 endogenous	 damage-associated	 molecules	
mediating	protective	responses	in	these	vascular	beds.		
On	the	other	hand,	sensory	TRP	channels	have	also	been	involved	in	modulating	the	vascular	
function	due	 to	 their	 involvement	 in	 sensing	environmental	 stimuli,	being	actual	 sensor	of	
thermal	challenges.	Thus,	we	examine	the	role	of	sensory	TRPA1	and	TRPM8	channels	and	the	
underlying	 mechanism	 in	 a	 local	 vascular	 response	 induced	 by	 low	 temperatures.	 Using	
pressure	myography	experiments	to	determine	changes	in	arterial	diameter,	we	showed	that	
TRPA1	 and	 TRPM8	 channels	 are	 involved	 in	 an	 intrinsic	 cold-induced	 vascular	 response	 in	
peripheral	arteries	and	the	global	cold-induced	potent	vasoconstriction	observed	is	the	sum	
of	the	activation	of	these	channels	in	sensory	and	sympathetic	nerve	endings.	These	results	
represent	the	first	evidence	for	an	intrinsic	response	to	cold	in	cutaneous	arteries	and	for	the	
functional	expression	of	TRPA1	and	TRPM8	channels	in	efferent	nerve	fibers,	suggesting	them	
as	the	most	potent	targets	in	the	treatment	of	cold-dependent	peripheral	vascular	diseases.	
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Altogether,	 we	 concluded	 that	 several	 sensory	 TRP	 channels	 play	 essential	 roles	 in	 the	
regulation	of	vascular	tone	in	response	to	chemical	and	thermal	stimuli.	
	
8.2	Resumen	
La	regulación	de	la	presión	arterial	es	un	proceso	fisiológico	esencial	principalmente	regulado	
por	el	tono	vascular	el	cual	depende	de	la	función	de	múltiples	canales	iónicos	que	determinan	
la	dinámica	en	la	concentración	del	calcio	intracelular	de	las	células	de	músculo	liso,	las	células	
endoteliales	 y	 los	 nervios	 perivasculares.	 Estudios	 recientes	 indican	 que	 los	 canales	 TRP	
sensoriales	 expresados	 en	 los	 nervios	 perivasculares	 pueden	 estar	 implicados	 en	 los	
mecanismos	 subyacentes	 a	 la	 regulación	 del	 tono	 arterial	 a	 través	 de	 la	 liberación	 de	
neuropeptidos	tales	como	el	CGRP	y	 la	noradrenalina	debido	a	su	capacidad	para	 influir	 la	
excitabilidad	 celular	 y	 la	 señalización	 intracelular	 del	 calcio.	 La	 función	 vascular	 de	 estos	
canales	 está	 asociada	 a	 sus	 propiedades	 quimio-	 y	 termo-	 sensoriales,	 sin	 embargo,	 su	
importancia	 en	 la	 regulación	 del	 tono	 vascular	 frente	 a	 estímulos	 externos	 sigue	 siendo	
desconocida.	
Dentro	de	la	familia	TRPM,	el	papel	de	los	canales	TRPM3	en	la	contribución	al	tono	vascular	
en	las	arterias	de	resistencia	aún	no	se	ha	establecido.	Por	lo	tanto,	al	estudiar	la	localización	
anatómica	de	estos	canales	mediante	el	uso	de	 la	microscopía	de	 inmunofluorescencia	en	
arterias	de	resistencia	y	patch	clamp	en	células	de	músculo	liso	aisladas,	encontramos	que	la	
expresión	 de	 TRPM3	 en	 arterias	 mesentéricas	 está	 restringida	 a	 los	 nervios	 sensoriales	
perivasculares.	Los	experimentos	de	miografía	de	presión	mostraron	que	la	activación	química	
de	 los	 canales	 TRPM3	 en	 las	 arterias	 mesentéricas	 mediante	 el	 empleo	 de	 un	 esteroide	
endógeno	llamado	PS	conduce	a	la	vasodilatación	de	la	arteria	mediante	la	liberación	de	CGRP	
de	 los	 nervios	 sensoriales	 perivasculares.	 Estos	 datos	 sobre	 la	 contribución	 de	 TRPM3	
identifican	a	estos	canales	como	dianas	terapéuticas	potenciales	para	la	modulación	del	tono	
de	las	arterias	de	resistencia	y	como	efectores	de	moléculas	asociadas	al	daño	endógeno	que	
median	las	respuestas	protectoras	en	los	lechos	vasculares.	
Por	otro	lado,	algunos	canales	sensoriales	de	la	familia	TRP	también	se	han	involucrado	en	la	
modulación	 de	 la	 función	 vascular	 debido	 a	 su	 participación	 en	 la	 detección	 de	 estímulos	
ambientales,	 identificándose	 como	 los	 sensores	 de	 los	 estímulos	 térmicos.	 Por	 lo	 tanto,	
examinamos	 los	 papeles	 de	 los	 canales	 sensoriales	 TRPA1	 y	 TRPM8	 y	 el	 mecanismo	
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subyacente	 de	 la	 respuesta	 vascular	 intrínseca	 y	 local	 inducida	 por	 bajas	 temperaturas.	
Usando	experimentos	de	miografía	de	presión	para	determinar	los	cambios	en	el	diámetro	
arterial,	demostramos	que	los	canales	TRPA1	y	TRPM8	están	involucrados	en	una	respuesta	
vascular	 intrínseca	 inducida	por	el	 frío	en	arterias	periféricas.	Además,	 la	 vasoconstricción	
inducida	por	frío	observada	es	la	suma	de	la	activación	de	estos	canales	que	estarían	presentes	
en	 las	 terminaciones	 nerviosas	 sensoriales	 y	 simpáticas.	 Estos	 resultados	 representan	 la	
primera	evidencia	de	una	respuesta	intrínseca	al	frío	en	las	arterias	cutáneas	además	de	una	
expresión	funcional	de	los	canales	TRPA1	y	TRPM8	en	las	fibras	nerviosas	simpáticas,	lo	que	
los	 sugiere	 como	 posibles	 objetivos	 potentes	 en	 el	 tratamiento	 de	 las	 enfermedades	
vasculares	 periféricas	 dependientes	 del	 frío.	 Finalmente,	 se	 llegó	 a	 la	 conclusión	 de	 que	
algunos	canales	sensoriales	de	la	familia	TRP	desempeñan	funciones	de	gran	relevancia	en	la	
regulación	del	tono	vascular	frente	a	estímulos	químicos	y	térmicos.	
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